<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
- --------------------------------------------------------------------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) September 10, 1998
MONARCH DENTAL CORPORATION
(Exact Name of Registrant as Specified in Charter)
Delaware 0-22835 51-0363560
- --------------------------------------------------------------------------------
(State or Other (Commission (IRS Employer
Jurisdiction File Number) Identification No.)
of Incorporation)
4201 Spring Valley Road, Suite 320, Dallas, Texas 75244
- --------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code (972) 702-7446
N/A
- --------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
<PAGE> 2
Item 2. Acquisition or Disposition of Assets.
On September 10, 1998, Monarch Dental Corporation (the "Company")
acquired Valley Forge Dental Associates, Inc. ("Valley Forge"), a King of
Prussia, Pennsylvania based dental practice management company, which operates
57 dental offices with 130 dentists. The acquisition was structured as a merger
between a subsidiary of the Company and Valley Forge. The Company intends to
continue to operate Valley Forge as a dental practice management company.
In the acquisition, the Company issued 1,559,076 shares of the
Company's common stock, par value $.01 per share, to the former stockholders of
Valley Forge, and assumed approximately $42 million in debt and other related
costs. The purchase price was determined by negotiations between the parties.
The Company utilized its Credit Facility to repay certain of Valley Forge's
indebtedness at closing.
Item 5. Other Events.
In conjunction with the acquisition of Valley Forge, the Company
renegotiated its Credit Facility with a bank syndicate. Under the new agreement,
the Company's credit line increased to $75 million from $30 million.
The terms and conditions of the Credit Facility remained the same.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(a) Financial Statements of Business Acquired.
It is impracticable to file the financial statements required
by Item 7(a) with the initial filing of this Report on Form
8-K. Such financial statements will be filed by amendment to
this Report as soon as practicable and within 60 days after
the required filing date for this Report.
(b) Pro Forma Financial Information.
It is impracticable to file the pro forma financial
information required by Item 7(b) with the initial filing of
this Report on Form 8-K. Such pro forma financial information
will be filed by amendment to this Report as soon as
practicable and within 60 days after the required filing date
for this Report.
(c) Exhibits
2.1 Agreement and Plan of Merger, dated as of September
1, 1998, by and among Monarch Dental Corporation,
Valley Forge Dental Associates, Inc., DFV Acquisition
Corp. and certain stockholders of Valley Forge Dental
Associates, Inc.
2.2 Registration Rights Agreement
2.3 Employment Agreement for Joseph J. Frank
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Monarch Dental Corporation
(Registrant)
Date: September 25, 1998 By: /s/ Steven G. Peterson
------------------------------
Name: Steven G. Peterson
Title: Chief Financial Officer
<PAGE> 4
EXHIBIT INDEX
<TABLE>
<CAPTION>
Exhibit Index Description
- ------------- -----------------------------------------------------
<S> <C>
2.1 Agreement and Plan of Merger, dated as of September
1, 1998, by and among Monarch Dental Corporation,
Valley Forge Dental Associates, Inc., DFV Acquisition
Corp. and certain stockholders of Valley Forge Dental
Associates, Inc.
2.2 Registration Rights Agreement
2.3 Employment Agreement for Joseph J. Frank
</TABLE>
<PAGE> 1
EXHIBIT 2.1
AGREEMENT AND PLAN OF MERGER
AMONG
VALLEY FORGE DENTAL ASSOCIATES, INC.
AND
THE PRINCIPAL STOCKHOLDERS AND MANAGEMENT STOCKHOLDERS THEREOF
AND
MONARCH DENTAL CORPORATION
AND
DFV ACQUISITION CORP.
DATED AS OF SEPTEMBER 1, 1998
<PAGE> 2
TABLE OF CONTENTS
<TABLE>
<CAPTION>
Page
----
<S> <C> <C> <C>
ARTICLE I
THE MERGER; EFFECTIVE TIME; CLOSING......................................................................1
1.1 THE MERGER......................................................................................1
1.2 EFFECTIVE TIME..................................................................................2
1.3 CLOSING.........................................................................................2
1.4 EFFECTS OF THE MERGER...........................................................................2
ARTICLE II
CERTIFICATE OF INCORPORATION AND
BY-LAWS OF THE SURVIVING CORPORATION.....................................................................2
2.1 CERTIFICATE OF INCORPORATION....................................................................2
2.2 THE BY-LAWS.....................................................................................2
ARTICLE III
DIRECTORS AND OFFICERS OF THE SURVIVING CORPORATION......................................................2
3.1 DIRECTORS.......................................................................................2
3.2 OFFICERS........................................................................................3
ARTICLE IV
MERGER CONSIDERATION; CONVERSION
OR CANCELLATION OF SHARES IN THE MERGER..................................................................3
4.1 SHARE CONSIDERATION FOR THE MERGER; CONVERSION OR CANCELLATION OF SHARES IN THE MERGER..........3
4.2 EXCHANGE AND PAYMENT PROCEDURES.................................................................5
4.3 FRACTIONAL SHARES...............................................................................6
4.4 ESCROW AGREEMENT................................................................................6
ARTICLE V
REPRESENTATIONS AND WARRANTIES...........................................................................7
5.1 REPRESENTATIONS AND WARRANTIES OF THE PRINCIPAL STOCKHOLDERS AND THE MANAGEMENT STOCKHOLDERS....7
5.2 REPRESENTATIONS AND WARRANTIES OF MONARCH.......................................................9
5.3 REPRESENTATIONS AND WARRANTIES OF THE COMPANY AND THE PRINCIPAL STOCKHOLDERS...................21
ARTICLE VI
CONDITIONS..............................................................................................37
6.1 CONDITIONS TO THE OBLIGATIONS OF THE COMPANY...................................................37
</TABLE>
(i)
<PAGE> 3
<TABLE>
<CAPTION>
Page
----
<S> <C> <C> <C>
6.2 CONDITIONS TO THE OBLIGATIONS OF MONARCH.......................................................39
ARTICLE VII
SURVIVAL; INDEMNIFICATION...............................................................................41
7.1 SURVIVAL OF REPRESENTATIONS, WARRANTIES, ETC. .................................................41
7.2 INDEMNIFICATION BY THE PRINCIPAL STOCKHOLDERS AND MANAGEMENT STOCKHOLDERS......................41
7.3 LIMITATIONS ON INDEMNIFICATION BY THE PRINCIPAL STOCKHOLDERS AND MANAGEMENT STOCKHOLDERS.......42
7.4 HOLDBACK SHARES................................................................................43
7.5 INDEMNIFICATION BY MONARCH.....................................................................45
7.6 LIMITATIONS ON INDEMNIFICATION BY MONARCH......................................................46
7.7 PAYMENT OF INDEMNIFICATION BY MONARCH..........................................................46
7.8 NOTICE; DEFENSE OF CLAIMS; LOSS REDUCTION .....................................................47
7.9 REMEDIES.......................................................................................48
ARTICLE VIII
MISCELLANEOUS AND GENERAL...............................................................................49
8.1 PAYMENT OF EXPENSES...................................................................49
8.2 [RESERVED].....................................................................................49
8.3 WAIVER OF CONDITIONS...........................................................................49
8.4 COUNTERPARTS...................................................................................49
8.5 GOVERNING LAW..................................................................................49
8.6 NOTICES........................................................................................49
8.7 ENTIRE AGREEMENT; ASSIGNMENT...................................................................50
8.8 PARTIES IN INTEREST............................................................................50
8.9 SEVERABILITY...................................................................................51
8.10 SPECIFIC PERFORMANCE...........................................................................51
8.11 ARBITRATION....................................................................................51
8.12 CAPTIONS.......................................................................................51
8.13 DIRECTOR AND OFFICER INDEMNIFICATION...........................................................52
8.14 GRANT OF OPTIONS...............................................................................52
</TABLE>
(ii)
<PAGE> 4
AGREEMENT AND PLAN OF MERGER
AGREEMENT AND PLAN OF MERGER (this "Agreement"), effective as of
September 1, 1998, by and among Valley Forge Dental Associates, a Delaware
corporation (the "Company"), the stockholders of the Company listed on the
signature page hereto (the "Principal Stockholders") and the directors and
executive officers of the Company listed on the signature page hereto (the
"Management Stockholders"), Monarch Dental Corporation, a Delaware corporation
("Monarch"), and DFV Acquisition Corp., a Delaware corporation and a wholly
owned subsidiary of Monarch ("Merger Sub").
W I T N E S S E T H:
WHEREAS, Monarch desires to acquire the Company and its subsidiaries
through a merger of Merger Sub with and into the Company;
WHEREAS, the Boards of Directors of the Company and Merger Sub each
have determined that it is in the best interests of their respective
stockholders for Merger Sub to merge with and into the Company upon the terms in
and subject to the conditions of this Agreement;
WHEREAS, the Board of Directors of Monarch has approved this Agreement
and the transactions contemplated thereby; and
WHEREAS, for federal income tax purposes, it is intended that the
Merger (as defined in Section 1.1) shall qualify as a reorganization within the
meaning of Section 368(a) of the Internal Revenue Code of 1986, as amended (the
"Code").
NOW, THEREFORE, based upon the above premises and in consideration of
the mutual representations, warranties, covenants and agreements set forth
herein, the parties hereby agree as follows:
ARTICLE I
THE MERGER; EFFECTIVE TIME; CLOSING
1.1 THE MERGER. Upon the terms and subject to the conditions set forth
in this Agreement, and in accordance with the General Corporation Law of the
State of Delaware (the "DGCL"), at the Effective Time (as defined in Section 1.2
below), Merger Sub and the Company shall consummate a merger (the "Merger") in
which (a) Merger Sub shall be merged with and into the Company and the separate
corporate existence of Merger Sub shall thereupon cease, and (b) the Company
shall continue as the surviving corporation in the Merger ("Surviving
Corporation") and shall succeed to and assume all of the rights, properties,
liabilities and obligations of Merger Sub.
<PAGE> 5
1.2 EFFECTIVE TIME. Subject to the provisions of this Agreement, Merger
Sub and the Company shall cause the Merger to be consummated by filing on the
Closing Date (as defined in Section 1.3) a Certificate of Merger (the
"Certificate of Merger") with the Secretary of State of the State of Delaware,
in such form as required by, and executed in accordance with, the relevant
provisions of the DGCL. The Merger shall become effective upon such filing or at
such time thereafter as is provided in the Certificate of Merger (the "Effective
Time"), although the parties agree that the Merger shall be effective as of
September 1, 1998 for financial statement purposes.
1.3 CLOSING. Subject to the satisfaction or waiver of the conditions
set forth in Article VI, the closing of the Merger (the "Closing") shall take
place at 10:00 a.m. on the second business day after satisfaction of the
conditions set forth in Article VI (or as soon as practicable thereafter
following satisfaction or waiver of the conditions set forth in Article VI) (the
"Closing Date"), at the offices of Monarch Dental Corporation, 4201 Spring
Valley Road, Suite 320, Dallas, TX 75244, unless another date, time or place is
agreed to in writing by Monarch, Merger Sub and the Company.
1.4 EFFECTS OF THE MERGER. The Merger shall have the effects set forth
in the applicable provisions of the DGCL.
ARTICLE II
CERTIFICATE OF INCORPORATION AND
BY-LAWS OF THE SURVIVING CORPORATION
2.1 CERTIFICATE OF INCORPORATION. At the Effective Time, the
Certificate of Incorporation of the Surviving Corporation shall be amended and
restated in the form attached hereto as Exhibit 2.1.
2.2 THE BY-LAWS. At the Effective Time, the By-Laws of the Surviving
Corporation shall be amended and restated in the form attached hereto as Exhibit
2.2.
ARTICLE III
DIRECTORS AND OFFICERS OF
THE SURVIVING CORPORATION
3.1 DIRECTORS. From and after the Effective Time, the Board of
Directors of the Surviving Corporation shall consist of Warren F. Melamed, Gary
W. Cage, Joseph J. Frank and Steven G. Peterson, until their successors have
been duly elected or appointed and qualified or until their earlier death,
resignation or removal in accordance with the Surviving Corporation's Amended
and Restated Certificate of Incorporation and Amended and Restated By-Laws. In
2
<PAGE> 6
connection therewith, the five members of the Board of Directors of the Company
at the date hereof shall have submitted resignations to be effective as of the
Effective Time.
3.2 OFFICERS. From and after the Effective Time, the officers of the
Surviving Corporation shall be those individuals listed on Schedule 3.2 attached
hereto until their successors have been duly elected or appointed and qualified
or until their earlier death, resignation or removal in accordance with the
Surviving Corporation's Amended and Restated Certificate of Incorporation and
Amended and Restated By-Laws.
ARTICLE IV
MERGER CONSIDERATION; CONVERSION
OR CANCELLATION OF SHARES IN THE MERGER
4.1 SHARE CONSIDERATION FOR THE MERGER; CONVERSION OR CANCELLATION OF
SHARES IN THE MERGER. The manner of converting or canceling shares of the
Company and the Surviving Corporation in the Merger shall be as follows:
4.1.1 Merger Consideration. Subject to Section 4.5, at the
Effective Time, each share of common stock, par value $.01 per share, of the
Company (the "Company Common Shares") issued and outstanding immediately prior
to the Effective Time (other than Company Common Shares owned by Merger Sub or
Monarch or any direct or indirect wholly owned subsidiary of Monarch
(collectively, the "Monarch Companies") or by the Company or any direct or
indirect wholly owned subsidiary of the Company, if any), shall, by virtue of
the Merger and without any action on the part of the holder thereof, be
converted into the right to receive 0.327868852 shares of common stock, par
value $.01 per share, of Monarch ("Monarch Common Shares"), such that Monarch
shall issue 1,559,111 shares at Closing in connection with the Merger (before
taking into account cash in lieu of fractional shares) and shall not issue more
than 2,050,000 Monarch Common Shares in connection with the Merger.
4.1.2 Share Cancellation. Each Company Common Share that is
directly owned by Monarch or any subsidiary thereof, if any, and each Company
Common Share that is directly owned by the Company or any subsidiary of the
Company shall be canceled and retired and shall cease to exist and no
consideration shall be delivered or deliverable in exchange therefor.
4.1.3 Status of Shares. All Company Common Shares to be
converted pursuant to this Section 4.1 shall, by virtue of the Merger and
without any action on the part of the holders thereof, cease to be outstanding,
be canceled and retired and cease to exist, and each holder of a certificate
representing any such Company Common Shares (a "Company Certificate") shall
thereafter cease to have any rights with respect to such Company Common Shares,
except the right to receive for each of the Company Common Shares upon the
surrender of such certificate in accordance with Section 4.2, the Merger
Consideration and cash in lieu of fractional Monarch Common Shares as
contemplated by Section 4.3. Each share of common stock of the Merger
3
<PAGE> 7
Sub outstanding immediately prior to the Effective Time shall be converted into
and become one fully paid and nonassessable share of common stock of the
Surviving Corporation.
4.1.4 Options. At the Effective Time, each outstanding option
to purchase Company Common Shares (each, an "Option") issued pursuant to the
Valley Forge Dental Associates 1997 Stock Option Plan (the "Option Plan"),
whether vested or unvested, shall be assumed by the Surviving Corporation and
shall constitute an option to acquire, on substantially the same terms and
subject to substantially the same conditions as were applicable under such
Option, including, without limitation, term, exercisability (with the exception
that such Options will accelerate and vest in full at the Effective Time),
status as an "incentive stock option" under Section 422 of the Code,
acceleration and termination provisions, the number of Monarch Common Shares,
rounded down to the nearest whole share, being equal to the product obtained by
multiplying the number of Company Common Shares subject to such Option
immediately prior to the Effective Time multiplied by .32787, at an exercise
price per Monarch Common Share (increased to the nearest whole cent) equal to
the quotient of the exercise price per Company Common Share immediately prior to
the Effective Time divided by .32787; provided, however, that in the case of any
Option to which Section 421 of the Code applies by reason of its qualification
as an incentive stock option under Section 422 of the Code, the conversion
formula shall be adjusted if necessary to comply with Section 424(a) of the
Code. Employment with the Company or any subsidiary thereof shall be credited to
holders of Options for purposes of determining the number of vested Monarch
Common Shares subject to exercise under converted Options after the Effective
Time. Except as set forth in this Section 4.1.4 or in Section 5.3.3 of the
Company Disclosure Schedule (as defined in Section 5.3.2), none of the Options
that is unvested at the Effective Time shall become vested as a result of the
execution and delivery of this Agreement or the consummation of the Merger. As
soon as practicable after the Effective Time, but no later than 30 days
thereafter, the Surviving Corporation shall deliver to the holders of Options
appropriate notices informing such holders that such options have been assumed
by the Surviving Corporation and will constitute options to purchase Monarch
Common Shares as provided above on substantially the same terms and conditions
as their options (subject to the adjustments required by this Section 4.1 after
giving effect to the Merger).
4.1.5 Convertible Notes. At the Effective Time, each
promissory note of the Company or any subsidiary of the Company which is
convertible into or exchangeable for Company Common Shares listed in Section
5.3.3 of the Company Disclosure Schedule (each, a "Convertible Note" and,
collectively, the "Convertible Notes") shall be assumed by the Surviving
Corporation and shall be deemed to constitute a promissory note convertible
into, on the terms and conditions as were applicable under such Convertible
Note, the same number of Monarch Common Shares and the same amount of cash as
the holder of such Convertible Note would have been entitled to receive pursuant
to the Merger had such holder converted such Convertible Note in full
immediately prior to the Effective Time (not taking into account whether such
Convertible Note was in fact convertible at such time), at a price per share
equal to (x) the aggregate conversion price for the Company Common Shares
subject to such Convertible Note divided by (y) the number of Company Common
Shares deemed purchasable pursuant to such Convertible Note.
4
<PAGE> 8
4.2 EXCHANGE AND PAYMENT PROCEDURES.
4.2.1 Share Exchange. At or as soon as practicable after the
Effective Time, Monarch shall make available, and each holder of common stock of
the Company (each a "Company Stockholder") will be entitled to receive, upon
surrender to Monarch of one or more Company Certificates for cancellation with a
letter of transmittal in the form attached hereto as Exhibit 4.2.1 (the "Letter
of Transmittal"), certificates from Monarch's transfer agent representing the
number of shares of Monarch Common Shares ("Monarch Certificates") that such
Company Stockholder is entitled to receive pursuant to Section 4.1 hereof, plus
the cash payments that such Company Stockholder is entitled to receive in
accordance with Section 4.2.2; provided, however, that the Company Certificates
representing the Monarch Common Shares described in Section 7.4 hereof (the
"Holdback Shares") shall be delivered into escrow in accordance with Section 7.4
of this Agreement. The Monarch Certificates that each Company Stockholder shall
be entitled to receive pursuant to the Merger shall be deemed to have been
issued at the Effective Time.
4.2.2 Cash Payments. Reserved.
4.2.3 Delivery of Common Certificates. As soon as reasonably
practicable after the Effective Time, the Surviving Corporation shall instruct
Monarch's transfer agent and the Paying Agent to mail to each holder of record
(other than holders of excluded shares as contemplated by Section 4.1.2) of a
certificate for Company Common Shares, (i) the Letter of Transmittal (which
shall specify that delivery shall be effected, and risk of loss and title to the
Certificates shall pass, only upon proper delivery of the certificates for
Company Common Shares to the Paying Agent and shall be in such form and have
such other provisions as the Surviving Corporation reasonably may specify) and
(ii) instructions for use in effecting the surrender of the certificates for
Company Common Shares in exchange for the Merger Consideration. Upon surrender
of a certificate for Company Common Shares for cancellation to the Paying Agent
together with the Letter of Transmittal, duly executed, and such other customary
documents as may be required pursuant to such instructions, the holder of such
certificate shall be delivered and paid the Merger Consideration in respect of
such Company Common Shares and the certificate for such Company Common Shares so
surrendered shall forthwith be canceled. Until surrendered in accordance with
the provisions of this Section 4.2.3, each certificate for Company Common Shares
(other than certificates representing excluded shares as contemplated by Section
4.1.2) shall represent for all purposes only the right to receive the Merger
Consideration without any interest thereon, less any required withholding taxes.
In the event that any certificate shall have been lost, stolen or destroyed, the
Paying Agent will pay in exchange for such lost, stolen or destroyed certificate
the Merger Consideration deliverable in respect thereof pursuant to this
Agreement upon the delivery of a duly executed affidavit of that fact by the
Person (as hereinafter defined) claiming such certificate to be lost, stolen or
destroyed and, if required by Monarch, the posting by such Person of a bond in
such reasonable amount as Monarch may direct as indemnity against any claim that
may be made against it with respect to such certificate.
5
<PAGE> 9
4.2.4 Interest; Taxes. No interest shall accrue on the Merger
Consideration. If the Merger Consideration (or any portion thereof) or such
payments are to be delivered to any person other than the person in whose name
the applicable certificates surrendered in exchange therefor is registered, it
shall be a condition to such exchange that the person requesting such exchange
shall pay to Monarch any transfer or other taxes required by reason of the
payment of the applicable consideration to a person other than the registered
holder of the certificate(s) so surrendered, or shall establish to the
satisfaction of Monarch that such tax has been paid or is not applicable.
Notwithstanding the foregoing, neither Monarch nor any other party hereto shall
be liable to a holder of Company Common Shares for any amount delivered to a
public official pursuant to applicable abandoned property, escheat and similar
laws.
4.2.5 Termination of Payment Fund; Interest. Any portion of
the Payment Fund which remains undistributed to the holders of Company Common
Shares for 270 days after the Effective Time shall be delivered to the Surviving
Corporation, upon demand. Any holders of Company Common Shares who have not
theretofore complied with this Article IV and the instructions set forth in the
Letter of Transmittal mailed to such holder after the Effective Time shall
thereafter look only to the Surviving Corporation for payment to which they are
entitled. All interest accrued in respect of the Payment Fund shall inure to the
benefit of and be paid to the Surviving Corporation.
4.2.6 Withholding Rights. The Surviving Corporation shall be
entitled to deduct and withhold from the consideration otherwise payable
pursuant to this Agreement to any holder of shares of Company Common Shares such
amounts as the Surviving Corporation is required to deduct and withhold with
respect to the making of such payment under the Code, or any provision of state,
local or foreign tax law. To the extent that amounts are so withheld by the
Surviving Corporation, such withheld amounts shall be treated for all purposes
of this Agreement as having been paid to the holder of the shares of Company
Common Shares in respect of which such deduction and withholding was made by the
Surviving Corporation.
4.2.7 Stock Transfer Books. After the Effective Time, there
shall be no transfers of any Company Common Shares on the stock transfer books
of the Surviving Corporation. If, after the Effective Time, Company Certificates
are presented to the Surviving Corporation, they shall be canceled and exchanged
in accordance with this Section 4.2.
4.3 FRACTIONAL SHARES. No fractional Monarch Common Shares will be
issued in connection with the Merger, but in lieu thereof, the holder of any
Company Common Shares who would otherwise be entitled to receive a fraction of a
Monarch Common Share will receive from Monarch promptly after the Effective
Time, an amount of cash equal to such fraction multiplied by the per share
market value of a Monarch Common Share which for purposes of this Agreement
shall be $15.25.
4.4 ESCROW AGREEMENT. Pursuant to an Escrow Agreement to be entered
into on or before the Closing Date in substantially the form of Exhibit 4.4
hereto among Monarch, Foster Management Company, as representative of the
Principal Stockholders and the
6
<PAGE> 10
Management Stockholders, and State Street Bank and Trust Company, as Escrow
Agent (the "Escrow Agreement"), Monarch will withhold, pro rata, from the Merger
Consideration that would otherwise be delivered to the Principal Stockholders
and the Management Stockholders 122,288 of the Monarch Common Shares issued in
connection with the Merger. Within two (2) business days following the Closing
Date, Monarch will deposit or cause to be deposited in escrow pursuant to the
Escrow Agreement certificates representing the shares thus withheld. The
Principal Stockholders and the Management Stockholders will execute and deliver
to the Escrow Agent contemporaneously with delivery of a Letter of Transmittal,
pursuant to the Escrow Agreement, a stock power in substantially the form of
Exhibit A to the Escrow Agreement.
4.5 DISSENTING SHARES. Notwithstanding any other provisions of this
Agreement to the contrary, Company Common Shares that are outstanding
immediately prior to the Effective Time and which are held by stockholders who
shall have not voted in favor of the Merger or consented thereto in writing and
who shall have demanded properly in writing appraisal for such shares in
accordance with Section 262 of the DGCL (collectively, the "Dissenting Shares")
shall not be converted into or represent the right to receive the Merger
Consideration. Such stockholders instead shall be entitled to receive payment of
the appraised value of such Company Common Shares held by them in accordance
with the provisions of such Section 262, except that all Dissenting Shares held
by stockholders who shall have failed to perfect or who effectively shall have
withdrawn or lost their rights to appraisal of such Company Common Shares under
such Section 262 shall thereupon be deemed to have been converted into and to
have become exchangeable, as of the Effective Time, for the right to receive,
without any interest thereon, the Merger Consideration upon surrender in the
manner provided in Section 4.2 of the certificate or certificates that,
immediately prior to the Effective Time, evidenced such Company Common Shares.
ARTICLE V
REPRESENTATIONS AND WARRANTIES
5.1 REPRESENTATIONS AND WARRANTIES OF THE PRINCIPAL STOCKHOLDERS
AND THE MANAGEMENT STOCKHOLDERS.
5.1.1 Making of Representations and Warranties; Certain
Definitions.
(a) As a material inducement to Monarch entering
into this Agreement and consummating the transactions contemplated hereby, each
of the Principal Stockholders and the Management Stockholders, severally and not
jointly, hereby makes to Monarch as of the date hereof and as of the Closing
Date the representations and warranties contained in this Section 5.1.
(b) For purposes of this Agreement, references
to a "Person" shall mean an individual, a corporation, an association, an
estate, a trust, a partnership or any other entity or organization.
7
<PAGE> 11
5.1.2 Ownership of Capital Stock. Each of the Principal
Stockholders and the Management Stockholders owns beneficially and of record the
number of the Company Common Shares set forth opposite such Stockholder's name
on Schedule 5.1.2 hereto. Except as set forth on Schedule 5.1.2, the Company
Common Shares held by such Principal Stockholder and such Management Stockholder
are free and clear of any and all liens, claims, options, charges, encumbrances,
rights or restrictions of any kind or nature other than restrictions imposed by
federal and state securities laws ("Claims").
5.1.3 Authority of the Stockholders. Each of the Principal
Stockholders which is not an individual has full authority under its applicable
limited partnership agreement or other governing documents to enter into this
Agreement and each agreement, document and instrument to be executed and
delivered by or on behalf of such Principal Stockholder pursuant to or as
contemplated by this Agreement and to carry out the transactions contemplated
hereby and thereby. This Agreement and all of the agreements, documents and
instruments to be executed and delivered by each of the Principal Stockholders
and the Management Stockholders pursuant to or as contemplated by this Agreement
constitute, or when executed and delivered by such Principal Stockholder or such
Management Stockholder will constitute, valid and binding obligations of such
Principal Stockholder or such Management Stockholder enforceable in accordance
with their respective terms.
5.1.4 Securities Act Matters. Each of the Principal
Stockholders hereby acknowledges, represents and warrants to Monarch as follows:
(a) Each Principal Stockholder represents that it
is an "accredited investor" as such term is defined in Rule 501 under the
Securities Act of 1933, as amended (the "Securities Act"), except as set forth
on Schedule 5.1.4. Each Principal Stockholder represents to Monarch that it is
acquiring the Monarch Common Shares for its own account, for investment only and
not with a view to, or any present intention of, effecting a distribution of
such securities or any part thereof except pursuant to a registration or an
available exemption under applicable law. Each such Principal Stockholder
acknowledges that its respective Monarch Common Shares have not been registered
under the Securities Act or the securities laws of any state or other
jurisdiction and cannot be disposed of unless they are subsequently registered
under the Securities Act and any applicable state laws or an exemption from such
registration is available.
(b) Legend. It is understood that the
certificates evidencing the Monarch Common Shares shall bear the following
restrictive legend:
"THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAW
OF ANY STATE, AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF EXCEPT
PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT AND APPLICABLE
STATE SECURITIES LAWS OR PURSUANT TO AN APPLICABLE EXEMPTION TO THE REGISTRATION
REQUIREMENTS OF SUCH ACT AND SUCH LAWS."
8
<PAGE> 12
5.2 REPRESENTATIONS AND WARRANTIES OF MONARCH.
5.2.1 Making of Representations and Warranties; Certain
Definitions.
(a) As a material inducement to the Company and
the Principal Stockholders entering into this Agreement and consummating the
transactions contemplated hereby, Monarch hereby makes as of the date hereof the
representations and warranties contained in this Section 5.2.
(b) For purposes of this Agreement references
to: (i) a "Material Adverse Effect" on a Person shall mean a material adverse
effect on the properties, assets, business, condition (financial or otherwise)
or results of operations of such Person; provided, however, that a Material
Adverse Effect shall not include any adverse effect resulting from changes in
general market or economic conditions or conditions generally affecting the
dental care or dental care management industry; and (ii) the "knowledge" or
"best knowledge" of the Principal Stockholders and/or Monarch and/or the Company
or words of similar meaning shall be deemed to refer to the actual knowledge of
the existence or absence of facts or information of any of the Principal
Stockholders or any officers of Monarch or the Company and such knowledge which
such person reasonably ought to have if such person had conducted a reasonable
inquiry under the circumstances of the matter in question.
5.2.2 Organization, Existence and Corporate Authority.
(a) Except as disclosed in Section 5.2.2 of the
Disclosure Schedule delivered by Monarch under this Agreement (the "Monarch
Disclosure Schedule"), Monarch and each of its Subsidiaries (as defined below),
including Merger Sub, is a corporation or limited partnership duly organized,
validly existing and in good standing under the DGCL or the laws of the state of
its incorporation, and is duly qualified or registered as a foreign corporation
or entity in each jurisdiction (i) listed in Section 5.2.2 of the Monarch
Disclosure Schedule and (ii) in which it is required to be licensed or qualified
to conduct its businesses or own its properties, except where the failure to so
qualify or register would not have a Material Adverse Effect on Monarch and its
Subsidiaries, taken as a whole. Except as disclosed in Section 5.2.2 of the
Monarch Disclosure Schedule, Monarch and each of its Subsidiaries has all
requisite corporate or partnership power and authority to conduct its business
as presently conducted. True and complete copies of the charter and By-laws (or
comparable documents) of Monarch and each of its Subsidiaries have previously
been delivered to the Company. Neither Monarch nor any of its Subsidiaries is in
violation of any term of its charter or By-laws (or comparable documents).
(b) Monarch and Merger Sub have full corporate
power and authority to enter into this Agreement and each agreement, document
and instrument to be executed and delivered by or on behalf of them pursuant to
or as contemplated by this Agreement and to carry out the transactions
contemplated hereby and thereby, subject to the approval of the holder of Merger
Sub's outstanding common stock by written consent in lieu of a special meeting
thereof. This Agreement and all agreements, documents and instruments to be
executed and delivered by
9
<PAGE> 13
Monarch and Merger Sub pursuant to or as contemplated by this Agreement
constitute, or when executed and delivered by such Person will constitute, valid
and binding obligations of such Person or Persons enforceable in accordance with
their respective terms. The execution, delivery and performance by Monarch and
Merger Sub of this Agreement and each such agreement, document and instrument:
(i) do not violate the Certificate of
Incorporation or By-laws of Monarch or Merger Sub or violate any laws,
rules or regulations of the United States or any state or other
jurisdiction applicable to Monarch or any of its Subsidiaries
(including Merger Sub), or require Monarch or Merger Sub to obtain any
approval, consent or waiver of, or to make any filing with, any Person
(governmental or otherwise) (assuming the Company is not a "person"
with total assets or sales in excess of $100,000,000 for purposes of
Section 18a of the Hart-Scott-Rodino Antitrust Improvements Act of
1976, as amended (the "HSR Act")) that has not been obtained or made,
except for the filing of the Certificate of Merger or as set forth on
Section 5.2.2(b)(i) of the Monarch Disclosure Schedule; and
(ii) do not result in a breach of,
constitute a default under, accelerate any obligation under or give
rise to a right of termination of any material indenture or loan or
credit agreement or any other material agreement, contract (including
without limitation any stock option agreement), instrument, mortgage,
lien, lease, permit, authorization, order, writ, judgment, injunction,
decree, determination or arbitration award to which Monarch or Merger
Sub is a party or by which the property of Monarch or Merger Sub is
bound or affected, or result in the creation or imposition of any
mortgage, pledge, lien, security interest or other charge or
encumbrance on any of the assets or properties of Monarch or any of its
Subsidiaries (including Merger Sub) except as set forth in Section
5.2.2(b)(ii) of the Monarch Disclosure Schedule.
5.2.3 Capitalization.
(a) The total authorized capital stock of
Monarch and the number of shares of capital stock of Monarch issued and
outstanding as of the date hereof is as set forth in Section 5.2.3 of the
Monarch Disclosure Schedule. All of such issued and outstanding shares of
capital stock of Monarch are duly and validly issued, fully paid and
nonassessable. Except as set forth in Section 5.2.3 of the Monarch Disclosure
Schedule, (i) there are no outstanding subscriptions, options, warrants,
agreements, arrangements or commitments of any kind for or relating to the
issuance, or sale of, or outstanding securities convertible into or exchangeable
for, any shares of capital stock of any class or other equity interests of
Monarch; (ii) no person has any preemptive right, right of first refusal or
similar right to acquire any shares of Monarch or any other shares of capital
stock of Monarch; (iii) there are no restrictions on the transfer of any shares
of capital stock of Monarch, other than those imposed by relevant state and
federal securities laws; (iv) no person has any right to cause Monarch to effect
the registration under the Securities Act, of any shares of its capital stock or
any other securities (including debt securities); (v) Monarch has no obligation
to purchase, redeem or otherwise acquire any of its equity
10
<PAGE> 14
securities or any interests therein, or to pay any dividend or make any other
distribution in respect thereof; and (vi) there are no voting trusts,
stockholders' agreements, or proxies relating to any securities of Monarch.
(b) The Monarch Common Shares to be issued to
the Company stockholders pursuant to this Agreement have been duly authorized
for issuance, and such Monarch Common Shares, when issued and delivered to the
Company stockholders pursuant to this Agreement, shall be duly authorized,
validly issued, fully paid and non-assessable and will be free and clear of any
and all Claims other than pursuant to the terms of this Agreement.
5.2.4 Subsidiaries; Investments. A complete and correct list
of all of the direct and indirect Subsidiaries of Monarch is set forth in
Section 5.2.4 of the Monarch Disclosure Schedule. All of the outstanding shares
of capital stock or other equity interest of each such Subsidiary are duly
authorized, validly issued, fully paid and nonassessable and all of such shares
or other equity interest are owned beneficially and of record by Monarch free
and clear of all Claims. Except as set forth in Section 5.2.4 of the Monarch
Disclosure Schedule, and except for the professional corporations listed in
Section 5.2.4 of the Monarch Disclosure Schedule with which Monarch or one of
its Subsidiaries has entered into management services agreements (the "Monarch
P.C.s"), Monarch does not own or have any direct or indirect interest in or
control over any corporation, partnership, joint venture or other entity of any
kind. For purposes of this Agreement, the term "Subsidiary" means, with respect
to any Person, any corporation more than 50% of the outstanding voting
securities of which, or any partnership, joint venture or other entity more than
50% of the total equity interest of which, is directly or indirectly owned by
such Person.
5.2.5 Financial Statements; SEC Filings.
(a) Monarch has previously supplied to the
Company its audited consolidated balance sheets as at December 31, 1996 and
December 31, 1997, and the consolidated statements of operations and cash flows
for the fiscal years ended December 31, 1997, 1996 and 1995 as certified by
Arthur Andersen, the independent certified public accountants of Monarch, and
Monarch's unaudited consolidated balance sheet as of June 30, 1998, and the
related consolidated statements of operations and cash flows for the six-month
period then ended, all of which financial statements (including the footnotes
and schedules thereto in the case of audited statements and subject to
information therein noted) were prepared in accordance with generally accepted
accounting principles, consistently applied during the periods covered thereby,
are complete and correct in all material respects and fairly present the
consolidated financial position of Monarch and its Subsidiaries as of the dates
of such statements and their consolidated results of operations for the periods
covered thereby (subject, in the case of unaudited interim financial statements,
to year-end adjustments which will not be material).
(b) Monarch has made available to the Company a
true and complete copy of each report, registration statement and definitive
proxy statement filed by the Company with the Securities and Exchange Commission
(the "SEC") since July 17, 1997 (the "Monarch
11
<PAGE> 15
SEC Documents"), which are all the documents (other than preliminary material)
that Monarch was required to file with the SEC since such date. As of their
respective dates, the Monarch SEC Documents complied in all material respects
with the requirements of the Securities Act, or the Securities Exchange Act of
1934, as amended, as the case may be, and the rules and regulations of the SEC
thereunder applicable to such Monarch SEC Documents, and none of the Monarch SEC
Documents contained any untrue statement of a material fact or omitted to state
a material fact required to be stated therein or necessary to make the
statements therein, in light of the circumstances under which they were made,
not misleading.
5.2.6 Absence of Undisclosed Liabilities. Except as disclosed
in Section 5.2.6 of the Monarch Disclosure Schedule and to the extent reflected
or reserved against in the consolidated balance sheet of Monarch as of December
31, 1997 included in Section 5.2.5 of the Monarch Disclosure Schedule (the
"Monarch Base Balance Sheet"), Monarch has no liabilities or obligations of any
nature, whether accrued, absolute, contingent or otherwise, asserted or
unasserted, known or unknown, except liabilities (i) stated or adequately
reserved against on the Monarch Base Balance Sheet, (ii) incurred in the
ordinary course of business since the date of the Monarch Base Balance Sheet
consistent with the terms of this Agreement, or (iii) which would not reasonably
be expected to have a Material Adverse Effect on Monarch and its Subsidiaries,
taken as a whole.
5.2.7 Absence of Certain Developments. Monarch and its
Subsidiaries have conducted their business only in the ordinary course
consistent with past practice and, except as set forth in Section 5.2.7 of the
Monarch Disclosure Schedule and since the date of the Monarch Base Balance
Sheet, there has been no change in the condition, financial or otherwise, of
Monarch, its Subsidiaries and the Monarch P.C.s taken as a whole or in the
assets, liabilities, properties or business of Monarch and its Subsidiaries,
taken as a whole which such change by itself or in conjunction with all other
such changes, whether or not arising in the ordinary course of business, has had
or is reasonably likely to have a Material Adverse Effect on Monarch and its
Subsidiaries taken as a whole.
5.2.8 Transactions with Affiliates. Except as set forth in
Section 5.2.8 of the Monarch Disclosure Schedule, there are no loans, leases or
other continuing transactions between Monarch or any of its Subsidiaries and any
present or former stockholder, director or officer thereof, or, to the knowledge
of Monarch, any member of such officer's, director's or stockholder's immediate
family, or any person controlled by such officer, director or stockholder or his
or her immediate family including, without limitation, any transaction that
would be discloseable pursuant to Item 404 of SEC Regulation S-K. Except as set
forth in Section 5.2.8 of the Monarch Disclosure Schedule, no stockholder,
director or officer of Monarch or any of its Subsidiaries nor, to the best
knowledge of Monarch, any of their respective spouses or family members, owns
directly or indirectly on an individual or joint basis any material interest in,
or serves as an officer or director or in another similar capacity of, any
customer or supplier of Monarch or any of its Subsidiaries, or any organization
which has a material contract or arrangement with Monarch or any of its
Subsidiaries.
12
<PAGE> 16
5.2.9 Real and Personal Property.
(a) Real Property. Except as set forth in
Section 5.2.9 of the Monarch Disclosure Schedule, neither Monarch nor any of its
Subsidiaries owns or has ever owned any real property. All of the real property
leased by Monarch, each of its Subsidiaries and each Monarch P.C. is identified
in Section 5.2.9(a) of the Monarch Disclosure Schedule (herein referred to as
the "Monarch Leased Real Property").
(i) Status of Leases. Each of the
leases of Monarch Leased Real Property has been duly authorized and
executed by Monarch or the Subsidiary of Monarch or the Monarch P.C.
party thereto and, to the knowledge of Monarch, is in full force and
effect and constitutes the legal, valid and binding obligation of
Monarch or the Subsidiary of Monarch or the Monarch P.C. party thereto,
and is enforceable in accordance with its respective terms. Monarch or
the Subsidiary of Monarch or the Monarch P.C. party thereto has not
received notice of any material default under any of said leases which
has not been cured, nor has any event occurred which, with notice or
the passage of time, or both, would give rise to a default which is
reasonably likely to have a Material Adverse Effect on Monarch. To the
knowledge of Monarch, the other party to each of said leases is not in
default under any of said leases and there is no event which, with
notice or the passage of time, or both, would give rise to such a
default.
(ii) Consents. No consent or approval is
required with respect to the transactions contemplated by this
Agreement from the other parties to any lease of Monarch Leased Real
Property.
(iii) Condition of Real Property. Except
as set forth in Section 5.2.9(a) of the Monarch Disclosure Schedule and
to the knowledge of Monarch all premises on any Monarch Leased Real
Property are in good operating condition and repair (ordinary wear and
tear excepted), have been well maintained consistent with customary
standards of practice in the industry and there are no material defects
in the physical condition of any land, buildings or improvements
constituting part of the Monarch Leased Real Property that would result
in a material liability of Monarch, a Subsidiary of Monarch or a
Monarch P.C. with respect to such Monarch Leased Real Property.
(iv) Compliance with the Law. None of
Monarch, any of its Subsidiaries or any of the Monarch P.C.s has
received any notice from any governmental authority of any violation of
any law, ordinance, regulation, license, permit or authorization issued
with respect to any Monarch Leased Real Property that has not been
heretofore corrected and to the knowledge of Monarch no such violation
exists, which in either case is reasonably likely to have a Material
Adverse Effect on the operation or value of any Monarch Leased Real
Property. None of Monarch, any of its Subsidiaries or any of the
Monarch P.C.s has received any notice of any real estate tax deficiency
or assessment or is aware of any proposed deficiency, claim or
assessment with respect to
13
<PAGE> 17
any of the Monarch Leased Real Property, or any pending or threatened
condemnation thereof.
(b) Personal Property. Except as specifically
disclosed in Section 5.2.9(b) of the Monarch Disclosure Schedule or in the
Monarch Base Balance Sheet, Monarch, each of its Subsidiaries and each Monarch
P.C. has good and valid title to all personal property owned by it. To the
knowledge of Monarch, none of such personal property or assets is subject to any
mortgage, pledge, lien, conditional sale agreement, security title, encumbrance
or other charge except as specifically disclosed in Section 5.2.9(b) of the
Monarch Disclosure Schedule or in the Monarch Base Balance Sheet. The Monarch
Base Balance Sheet reflects all personal property of Monarch and its
Subsidiaries. Except as otherwise specified in Section 5.2.9(b) of the Monarch
Disclosure Schedule, all material items of leasehold improvements, furnishings,
machinery, equipment and other personal property of any kind or nature of
Monarch, its Subsidiaries or the Monarch P.C.s is in good repair (ordinary wear
and tear excepted), has been well maintained, is in good working order, and
substantially complies with all applicable laws, ordinances and regulations
except for any noncompliance therewith which would not have a Material Adverse
Effect on Monarch, its Subsidiaries and the Monarch P.C.s, taken as a whole.
5.2.10 Tax Matters.
(a) Each of Monarch and its Subsidiaries has
filed all federal, state, local and foreign tax returns required to be filed
through the date hereof, and has paid or caused to be paid all federal, state,
local, foreign, and other taxes, including without limitation income taxes,
estimated taxes, excise taxes, sales taxes, use taxes, premium taxes, gross
receipts taxes, franchise taxes, employment and payroll-related taxes,
withholding taxes, stamp taxes, transfer taxes, and property taxes, whether or
not measured in whole or in part by net income (collectively, "Taxes"), required
to be paid through the date hereof whether disputed or not, except taxes which
have not yet accrued or otherwise become due, for which adequate provision has
been made in the pertinent financial statements referred to in Section 5.2.5.
The provisions for taxes on the Monarch Base Balance Sheet and on the latest
balance sheet provided as described in Section 5.2.5 of this Agreement are
sufficient as of their respective dates for the payment of all accrued and
unpaid Taxes of any nature of Monarch, and any applicable Taxes owing by Monarch
to any foreign jurisdiction, whether or not assessed or disputed. All Taxes and
other assessments and levies which Monarch is required to withhold or collect
have been withheld and collected and have been paid over to the proper
governmental authorities except where the failure to withhold or collect and pay
over would not be reasonably likely to have a Material Adverse Effect on Monarch
and its Subsidiaries, taken as a whole. Neither the Internal Revenue Service nor
any other governmental authority is now asserting or, to the best knowledge of
Monarch, threatening to assert against Monarch any deficiency or claim for
additional Taxes. Except as set forth in Section 5.2.10 of the Monarch
Disclosure Schedule, neither Monarch nor any of its Subsidiaries has received
notice of any audit of any tax return filed by such person. Except as set forth
in Section 5.2.10 of the Monarch Disclosure Schedule, no waiver or agreement by
Monarch is in force for the extension of time for the assessment or payment of
any Taxes. Neither Monarch nor any of its Subsidiaries has received notice of
any claim made by an
14
<PAGE> 18
authority in a jurisdiction where Monarch or such Subsidiary does not file tax
returns that Monarch or such Subsidiary is or may be subject to taxation by that
jurisdiction. There are no security interests recorded or asserted on any of the
assets of Monarch or any of its Subsidiaries that arose in connection with any
failure (or alleged failure) to pay any Tax.
(b) Neither Monarch nor any of its Subsidiaries
has waived any statute of limitations in respect of Taxes or agreed to any
extension of time with respect to a Tax assessment or deficiency.
(c) Neither Monarch nor any of its Subsidiaries
has filed a consent under Section 341(f) of the Code concerning collapsible
corporations. Neither Monarch nor any of its Subsidiaries has made any payments,
is obligated to make any payments, or is party to any agreement that under
certain circumstances could obligate it to make any payments that will not be
deductible under Section 280G of the Code. Neither Monarch nor any of its
Subsidiaries has been a United States real property holding corporation within
the meaning of Section 897(c)(2) of the Code during the applicable period
specified in Section 897(c)(1)(A)(ii) of the Code. Each of Monarch and its
Subsidiaries has disclosed on its respective federal income tax returns all
positions taken therein that could give rise to a substantial understatement of
federal income Tax within the meaning of Section 6662 of the Code. Neither
Monarch nor any of its Subsidiaries is a party to any Tax allocation or sharing
agreement. Neither Monarch nor any of its Subsidiaries (A) has been a member of
an affiliated group filing a consolidated federal income tax return and (B) has
any liability for the Taxes of any Person under Treasury Regulation ss. 1.1502-6
(or any similar provision of state, local, or foreign law), as a transferee or
successor, by contract or otherwise.
5.2.11 Contracts and Commitments.
(a) To the knowledge of Monarch, all contracts,
agreements, leases and instruments to which Monarch, any of its Subsidiaries or
any Monarch P.C. is a party or by which any such entity is obligated have been
duly authorized by Monarch or the applicable Subsidiary of Monarch or Monarch
P.C., and, to the knowledge of Monarch, are valid and are in full force and
effect and constitute legal, valid and binding obligations of such entity, and,
to the knowledge of Monarch, are enforceable in accordance with their respective
terms, in each case, except to the extent that enforceability may be limited by
applicable bankruptcy, insolvency or similar laws affecting the enforcement of
creditors' rights generally and subject to general principles of equity. Monarch
does not know of any notice or threat of or basis for the termination,
expiration or modification of any such agreements within one year from the date
hereof, which termination, expiration or modification is reasonably likely to
have a Material Adverse Effect on Monarch and its Subsidiaries, taken as a
whole. Neither Monarch nor, to the best knowledge of Monarch, any other party to
any material contract, agreement or instrument of Monarch, any of its
Subsidiaries or any Monarch P.C., is in default in complying with any provisions
thereof, and no condition or event or fact exists which, with notice, lapse of
time or both would constitute a default thereunder on the part of Monarch or the
applicable Subsidiary of Monarch or Monarch P.C., or, to the best knowledge of
Monarch, any other party thereto, except
15
<PAGE> 19
for any such default, condition, event or fact that, individually or in the
aggregate, would not be reasonably likely to have a Material Adverse Effect on
Monarch and its Subsidiaries, taken as a whole.
(b) None of Monarch, any of its Subsidiaries or
any Monarch P.C. (i) has any liability for renegotiation of government contracts
or subcontracts, (ii) has been suspended or barred from bidding on contracts or
subcontracts with any federal, state or local agency or governmental authority,
(iii) has been audited or investigated by any such agency or authority with
respect to contracts entered into or goods and services provided by Monarch or
the applicable Subsidiary of Monarch or Monarch P.C. or (iv) has had a contract
terminated by any such agency or authority for default or failure to perform in
accordance with applicable standards.
5.2.12 Intellectual Property Rights; Employee Restrictions.
Except as set forth in Section 5.2.12 of the Monarch Disclosure Schedule, each
of Monarch, its Subsidiaries and the Monarch P.C.s (i) has exclusive ownership
of or an exclusive license or other rights to use its trademarks, trademark
applications, service marks, service mark applications, trade names, copyrights,
trade secrets, product designs and systems set forth in Section 5.2.12 of the
Monarch Disclosure Schedule and (ii) owns or has a valid license or other rights
to use its computer software listed in Section 5.2.12 of the Monarch Disclosure
Schedule (the "Software") and all other patents, patent applications,
trademarks, trademark applications, service marks, service mark applications,
trade names, copyrights, manufacturing processes and trade secrets (collectively
"Intellectual Property") material in the conduct of its business as presently
conducted and as proposed to be conducted. To the best knowledge of Monarch,
there are no infringements by any other person of any rights of Monarch, its
Subsidiaries and the Monarch P.C.s under any such Intellectual Property. No
claim is pending or, to the knowledge of Monarch, threatened against Monarch,
any of its Subsidiaries or any Monarch P.C. to the effect that any such
Intellectual Property infringes upon or conflicts with the asserted rights of
any other person and, to the knowledge of Monarch, there is no basis for any
such claim (whether or not pending or threatened). No claim is pending or, to
the knowledge of Monarch, threatened against Monarch, any of its Subsidiaries or
any Monarch P.C. to the effect that any such Intellectual Property is invalid or
unenforceable, and, to the knowledge of Monarch, there is no basis for any such
claim (whether or not pending or threatened).
5.2.13 Litigation. Except as disclosed in Section 5.2.13 of
the Monarch Disclosure Schedule, there is no litigation or governmental or
administrative proceeding or investigation pending or, to the knowledge of
Monarch, threatened against Monarch, any of its Subsidiaries or any Monarch P.C.
or affecting any of their respective properties or assets, or against any of
their respective officers, directors, stockholders, professional employees or
other key employees, or which may call into question the validity or hinder the
enforceability or performance of this Agreement or the agreements and
transactions contemplated hereby which, if decided adversely, would be
reasonably likely to have a Material Adverse Effect on Monarch and its
Subsidiaries, taken as a whole; nor, to the knowledge of Monarch, has there
occurred any event nor does there exist any condition or state of facts on the
basis of which any such claim
16
<PAGE> 20
may be asserted. To the knowledge of Monarch, no claim has been asserted against
Monarch, any of its Subsidiaries or any Monarch P.C. for renegotiation or price
redetermination of any business transaction. Section 5.2.13 of the Monarch
Disclosure Schedule sets forth a summary of all material litigation involving
Monarch, its Subsidiaries or any Monarch P.C.
5.2.14 Permits; Compliance with Laws.
(a) Except as disclosed in Section 5.2.14 of the
Monarch Disclosure Schedule, Monarch, each of its Subsidiaries and each Monarch
P.C. has all material franchises, authorizations, approvals, orders, consents,
licenses, certificates, permits, registrations, qualifications or other rights
and privileges (collectively "Permits") required in connection with the
ownership of its properties and the conduct of its business as the same is
presently conducted or proposed to be conducted and all such Permits are valid
and in full force and effect. No Permit is subject to termination as a result of
the execution of this Agreement or consummation of the transactions contemplated
hereby. Except as disclosed in Section 5.2.14 of the Monarch Disclosure
Schedule, Monarch, each of its Subsidiaries and each Monarch P.C. is now and has
heretofore been in compliance with all applicable statutes, ordinances, orders,
rules and regulations (including all applicable dental practice, OSHA, consumer
credit and environmental laws and regulations) promulgated by any federal,
state, municipal or other governmental authority which apply to the conduct of
its business except for such non-compliance as would not be reasonably expected
to have a Material Adverse Effect on Monarch and its Subsidiaries, taken as a
whole. None of Monarch, any of its Subsidiaries or any Monarch P.C. has ever
entered into or been subject to any judgment, consent decree, compliance order
or administrative order with respect to any law or received any request for
information, notice, demand letter, administrative inquiry or formal or informal
complaint or claim with respect to any environmental or health and safety matter
or the enforcement of any such law.
(b) None of Monarch, any of its Subsidiaries or
any Monarch P.C. is required to make filings under any insurance holding company
or similar state statute, or to be licensed or authorized as an insurance
holding company in any jurisdiction in order to conduct its business as
presently conducted. The dental services and related products offered and
provided by the Monarch P.C.s have been and are offered and provided in
compliance with the requirements of all relevant laws and regulations
(including, without limitation, consumer credit or similar laws relating to the
extension of credit or other financing by Monarch, any of its Subsidiaries or
any Monarch P.C. to patients receiving services of the Monarch P.C.s), except to
the extent of any non-compliance not having a Material Adverse Effect on Monarch
and its Subsidiaries, taken as a whole, and none of Monarch, any of its
Subsidiaries or any Monarch P.C. has received any notification from any
governmental regulatory authority to the effect that any Permit from such
regulatory authority is needed to be obtained by it in order to conduct its
business which has not been duly obtained.
(c) Each as set forth in Section 5.2.14 of the
Monarch Disclosure Schedule, Monarch is not aware of any legislation, rule or
regulation which shall either (i) have been proposed and be in its reasonable
judgment reasonably likely to be adopted in any of the
17
<PAGE> 21
states in which it presently conducts operations, in the foreseeable future, or
(ii) have been adopted in any of the states in which it presently conducts
operations in either case that, individually or in the aggregate, has a Material
Adverse Effect or could reasonably be anticipated to have a Material Adverse
Effect on Monarch and its Subsidiaries, taken as a whole.
5.2.15 Information Supplied to the Company. No statement
made in writing or other written information furnished by Monarch to the Company
or its representatives (including, but not limited to, Monarch's financial
statements, all information in the Monarch Disclosure Schedule and the other
Exhibits and Schedules hereto) or any other documents delivered in connection
with the transactions contemplated by this Agreement, contains any untrue
statement of a material fact or omits to state a material fact necessary in
order to make the statements so made or information so delivered not misleading.
5.2.16 Employee Benefit Programs.
(a) Section 5.2.16 of the Monarch Disclosure
Schedule sets forth a list of every Employee Program (as defined below)
currently maintained by Monarch or any of its Subsidiaries or any Monarch P.C.
(b) Each Employee Program which has been
maintained by Monarch, any of its Subsidiaries or any Monarch P.C. and which has
at any time been intended to qualify under Section 401(a) or 501(c)(9) of the
Code, has received a favorable determination or approval letter from the IRS
regarding its qualification under such section and has, in fact, been qualified
under the applicable section of the Code from the effective date of such
Employee Program through and including the Effective Time (or, if earlier, the
date that all of such Employee Program's assets were distributed). Except for
amendments made to the Code for which the remedial amendment period has not
expired, no event or omission has occurred which would cause any such Employee
Program to lose its qualification under the applicable Code section.
(c) There has not been any failure of any party
to comply with any laws applicable with respect to the Employee Programs that
have been maintained by Monarch, its Subsidiaries or any Monarch P.C. which is
reasonably likely to have a Material Adverse Effect on Monarch and its
Subsidiaries, taken as a whole. With respect to any Employee Program now or
heretofore maintained by Monarch, any of its Subsidiaries or any Monarch P.C.,
there has occurred no "prohibited transaction," as defined in Section 406 of the
Employee Retirement Income Security Act of 1974, as amended ("ERISA"), or
Section 4975 of the Code, or breach of any duty under ERISA or other applicable
law (including, without limitation, any health care continuation requirements or
any other tax law requirements, or conditions to favorable tax treatment,
applicable to such plan), which could result, directly or indirectly (including
without limitation through any obligation of indemnification or contribution),
in any taxes, penalties or other liability to Monarch or any Affiliate (as
defined below) which is reasonably likely to have a Material Adverse Effect on
Monarch and its Subsidiaries, taken as a whole. No litigation, arbitration, or
governmental administrative proceeding (or investigation) or
18
<PAGE> 22
other proceeding (other than those relating to routine claims for benefits) is
pending or, to the knowledge of Monarch, threatened with respect to any such
Employee Program which is reasonably likely to have a Material Adverse Effect on
Monarch and its Subsidiaries, taken as a whole.
(d) None of Monarch, any of its Subsidiaries or
any Monarch P.C. has incurred any liability under Title IV of ERISA which will
not be paid in full prior to the Effective Time. There has been no "accumulated
funding deficiency" (whether or not waived) with respect to any Employee Program
ever maintained by Monarch, any of its Subsidiaries or any Monarch P.C.s and
subject to Code Section 412 or ERISA Section 302. With respect to any Employee
Program maintained by Monarch, any of its Subsidiaries or any Monarch P.C. and
subject to Title IV of ERISA, there has been no (nor will there be any as a
result of the transaction contemplated by this Agreement) (i) "reportable
event," within the meaning of ERISA Section 4043, or the regulations thereunder
(for which the notice requirement is not waived under 29 C.F.R. Part 2615) and
(ii) event or condition which presents a material risk of plan termination or
any other event that may cause Monarch, any of its Subsidiaries or any Monarch
P.C. to incur liability or have a lien imposed on its assets under Title IV of
ERISA. All payments and/or contributions required to have been made (under the
provisions of any agreements or other governing documents or applicable law)
with respect to all Employee Programs heretofore maintained by Monarch, any of
its Subsidiaries or any Monarch P.C., for all periods prior to the Effective
Time, either have been made or have been accrued (and all such unpaid but
accrued amounts are described on Section 5.2.16 of the Monarch Disclosure
Schedule). Except as described in Section 5.2.16 of the Monarch Disclosure
Schedule, no Employee Program maintained by Monarch, any of its Subsidiaries or
any Monarch P.C. and subject to Title IV of ERISA (other than a Multi-employer
Plan) has any "unfunded benefit liabilities" within the meaning of ERISA Section
4001(a)(18), as of the Closing Date. None of Monarch, any of its Subsidiaries or
any Monarch P.C. has ever maintained a Multiemployer Plan. None of the Employee
Programs ever maintained by Monarch, any of its Subsidiaries or any Monarch P.C.
has ever provided health care or any other non-pension benefits to any employees
after their employment was terminated (other than as required by part 6 of
subtitle B of title I of ERISA) or has ever promised to provide such
post-termination benefits.
(e) For purposes of this Section 5.2.16 and
Section 5.3.18:
(i) "Employee Program" means (A) all
employee benefit plans within the meaning of ERISA Section 3(3),
including, but not limited to, multiple employer welfare arrangements
(within the meaning of ERISA Section 3(40)), plans to which more than
one unaffiliated employer contributes and employee benefit plans (such
as foreign or excess benefit plans) which are not subject to ERISA; and
(B) all stock option plans, bonus or incentive award plans, severance
pay policies or agreements, deferred compensation agreements,
supplemental income arrangements, vacation plans, and all other
employee benefit plans, agreements, and arrangements not described in
(A) above. In the case of an Employee Program funded through an
organization described in
19
<PAGE> 23
Code Section 501(c)(9), each reference to such Employee Program shall
include a reference to such organization;
(ii) an entity "maintains" an Employee Program if such
entity sponsors, contributes to, or provides (or has promised to
provide) benefits under such Employee Program, or has any obligation
(by agreement or under applicable law) to contribute to or provide
benefits under such Employee Program, or if such Employee Program
provides benefits to or otherwise covers employees of such entity (or
their spouses, dependents, or beneficiaries);
(iii) an entity is an "Affiliate" of Monarch or the
Company, as applicable, if it would have ever been considered a single
employer with Monarch or the Company, as applicable, under ERISA
Section 4001(b) or part of the same "controlled group" as Monarch or
the Company, as applicable, for purposes of ERISA Section 302(d)(8)(C);
and
(iv) "Multiemployer Plan" means a (pension or non-pension)
employee benefit plan to which more than one employer contributes and
which is maintained pursuant to one or more collective bargaining
agreements.
5.2.17 Environmental Matters, Hazardous Waste, Etc. No
hazardous wastes, substances or materials or oil or petroleum products have been
generated, transported, used, disposed, stored or treated by Monarch, any of its
Subsidiaries or any Monarch P.C. and no material amount of hazardous wastes,
substances or materials, or oil or petroleum products have been released,
discharged, disposed, transported, placed or otherwise caused to enter the soil
or water in, under or upon any real property owned, leased or operated by
Monarch, any of its Subsidiaries or any Monarch P.C., in each case in violation
of any applicable federal, state or local law, regulation, rule or order which
violation remains uncorrected.
5.2.18 Insurance. The physical properties, assets, business,
operations, employees, officers and directors of Monarch, its Subsidiaries and
the Monarch P.C.s are insured to the extent disclosed in Section 5.2.18 of the
Monarch Disclosure Schedule. There is no claim by Monarch, any of its
Subsidiaries or any Monarch P.C. pending under any such policies as to which
coverage has been questioned, denied or disputed by the insurer. Said insurance
policies and arrangements are in full force and effect, all premiums with
respect thereto are currently paid, and Monarch, its Subsidiaries and the
Monarch P.C.s are in compliance in all material respects with the terms thereof.
The professional malpractice insurance coverage of Monarch, its Subsidiaries and
the Monarch P.C.s complies in all material respects with all requirements of
applicable law and Monarch, its Subsidiaries and the Monarch P.C.s have obtained
the necessary insurance coverage to comply with all agreements and leases to
which any of them is a party. Each such insurance policy shall continue to be in
full force and effect following consummation of the transactions contemplated by
this Agreement.
20
<PAGE> 24
5.2.19 Relationship with Customers and Plans. No dental
insurance plan, managed care plan or similar plan which accounted for more than
5% of the consolidated revenues of Monarch for the fiscal year ended December
31, 1997 or which is otherwise significant to Monarch has canceled or otherwise
terminated its relationship with Monarch or any of the Monarch P.C.s, or has
during said period decreased materially its usage or purchase of the services or
products of Monarch, any of its Subsidiaries or any of the Monarch P.C.s. No
such plan or supplier has, to the knowledge of Monarch, any plan or intention to
terminate, to cancel or otherwise materially and adversely modify its
relationship with Monarch, any of its Subsidiaries or any of the Monarch P.C.s,
nor has Monarch received any notice or information concerning the foregoing.
5.2.20 Absence of Questionable Payments. Neither Monarch nor
any of its Subsidiaries, nor to the knowledge of Monarch, any director, officer,
agent, employee or other Person acting on behalf of Monarch or any of its
Subsidiaries, has used any funds of Monarch or any of its Subsidiaries for
unlawful contributions, payments, gifts or entertainment, or made any unlawful
expenditures relating to political activity to domestic or foreign government
officials or others. Monarch has adequate financial controls to prevent such
improper or unlawful contributions, payments, gifts, entertainment or
expenditures. None of Monarch or any of its Subsidiaries, or to the knowledge of
Monarch, any current director, officer, agent, employee or other Person acting
on behalf of Monarch or any of its Subsidiaries, has accepted or received any
unlawful contributions, payments, gifts or expenditures. Each of Monarch and its
Subsidiaries has as at all times complied, and is in compliance, in all respects
with the U.S. Foreign Corrupt Practices Act and all foreign laws and regulations
relating to prevention of corrupt practices and similar matters.
5.2.21 Investment Banking; Brokerage. There are no claims for
investment banking fees, brokerage commissions, finder's fees or similar
compensation (exclusive of professional fees of lawyers and accountants) in
connection with the transactions contemplated by this Agreement based on any
arrangement or agreement made by or on behalf of Monarch, except as set forth in
Section 5.2.21 of the Monarch Disclosure Schedule.
5.3 REPRESENTATIONS AND WARRANTIES OF THE COMPANY AND THE
PRINCIPAL STOCKHOLDERS
5.3.1 Making of Representations and Warranties. As a material
inducement to Monarch entering into this Agreement and consummating the
transactions contemplated hereby, the Company and the Principal Stockholders
hereby make as of the date hereof the representations and warranties contained
in this Section 5.3.
5.3.2 Organization, Existence and Authority.
(a) Except as disclosed in Section 5.3.2 of the
Disclosure Schedule delivered by the Company under this Agreement (the "Company
Disclosure Schedule"), the Company and each of its Subsidiaries is a corporation
duly organized, validly existing and in
21
<PAGE> 25
good standing under the jurisdiction of its incorporation, and is duly qualified
or registered as a foreign corporation in each jurisdiction (i) listed in
Section 5.3.2 of the Company Disclosure Schedule and (ii) in which it is
required to be licensed or qualified to conduct its businesses or own its
properties, except where the failure to so qualify or register would not have a
Material Adverse Effect on the Company and its Subsidiaries, taken as a whole.
Except as disclosed in Section 5.3.2 of the Company Disclosure Schedule, the
Company and each of its Subsidiaries has all requisite corporate power and
authority to conduct its business as presently conducted. True and complete
copies of the charter and By-laws of the Company and each of its Subsidiaries as
in effect immediately prior to the Effective Time have previously been made
available to Monarch. Neither the Company nor any of its Subsidiaries is in
violation of any term of its charter or By-laws.
(a) The Company has full corporate power and
authority to enter into this Agreement and each agreement, document and
instrument to be executed and delivered by or on behalf of it pursuant to or as
contemplated by this Agreement and to carry out the transactions contemplated
hereby and thereby, subject to the approval of the Company Stockholders by
written consent in lieu of a special meeting thereof pursuant to Section 6.1.2
hereof. This Agreement and all agreements, documents and instruments to be
executed and delivered by the Company pursuant to or as contemplated by this
Agreement constitute, or when executed and delivered by the Company will
constitute, valid and binding obligations of the Company enforceable in
accordance with their respective terms. The execution, delivery and performance
by the Company of this Agreement and each such agreement, document and
instrument:
(i) do not violate the Certificate of
Incorporation or By-laws of the Company or any of its Subsidiaries or
violate any laws, rules or regulations of the United States or any
state or other jurisdiction applicable to the Company or any of its
Subsidiaries, or require the Company to obtain any approval, consent
or waiver of, or to make any filing with, any Person (governmental or
otherwise including, without limitation, the HSR Act) that has not
been obtained or made, except for the filing of the Certificate of
Merger or as set forth on Section 5.3.2(b)(i) to the Company
Disclosure Schedule; and
(ii) do not result in a breach of,
constitute a default under, accelerate any obligation under or give
rise to a right of termination of any material indenture or loan or
credit agreement or any other material agreement, contract (including
without limitation any stock option agreement), instrument, mortgage,
lien, lease, permit, authorization, order, writ, judgment, injunction,
decree, determination or arbitration award to which the Company or any
of its Subsidiaries is a party or by which the property of the Company
or any of its Subsidiaries is bound or affected except as contemplated
in Section 4.1.4 hereof or as set forth in Section 5.2.3(b) of the
Company Disclosure Schedule, or result in the creation or imposition
of any mortgage, pledge, lien, security interest or other charge or
encumbrance on any of the assets or properties of the Company or any
of its Subsidiaries except for such consents or waivers which have
been obtained.
22
<PAGE> 26
5.3.3 Capitalization; Validity of the Company Common Shares.
The total authorized capital stock of the Company and the number of shares of
capital stock and options, convertible securities and warrants of the Company
issued and outstanding as of the date hereof is as set forth in Section 5.3.3 of
the Company Disclosure Schedule. All of such issued and outstanding shares of
capital stock of the Company are duly and validly issued, fully paid and
nonassessable and all outstanding shares, options, convertible securities and
warrants are owned of record and beneficially by the stockholders or option or
warrantholders indicated to own such securities on Section 5.3.3 of the Company
Disclosure Schedule. No shares of capital stock of the Company are held in the
treasury of the Company. Except as set forth in Section 5.3.3 of the Company
Disclosure Schedule, (i) there are no outstanding subscriptions, options,
warrants, agreements, arrangements or commitments of any kind for or relating to
the issuance, or sale of, or outstanding securities convertible into or
exchangeable for, any shares of capital stock of any class or other equity
interests of the Company; (ii) no person has any preemptive right, right of
first refusal or similar right to acquire, any shares of capital stock of the
Company; (iii) there are no restrictions on the transfer of any shares of
capital stock of the Company, other than those imposed by relevant state and
federal securities laws or this Agreement; (iv) no person has any right to cause
the Company to effect the registration under the Securities Act, of any shares
of its capital stock or any other securities (including debt securities); (v)
the Company has no obligation to purchase, redeem or otherwise acquire any of
its equity securities or any interests therein, or to pay any dividend or make
any other distribution in respect thereof; (vi) there are no voting trusts,
stockholders' agreements, or proxies relating to any securities of the Company;
and (vii) no option, warrant, convertible securities or other security of the
Company is subject to redemption or accelerated vesting upon or by reason of the
transactions contemplated hereby.
5.3.4 Subsidiaries; Investments. A complete and correct list
of all of the direct and indirect Subsidiaries of the Company is set forth in
Section 5.3.4 of the Company Disclosure Schedule, all of the outstanding shares
of capital stock of each such Subsidiary are duly authorized, validly issued,
fully paid and nonassessable and except as set forth in Section 5.3.4 of the
Company Disclosure Schedule, all of such shares are owned beneficially and of
record by the Company free and clear of all Claims. Except as set forth in
Section 5.3.4 of the Company Disclosure Schedule, and except for the
professional corporations listed in Section 5.3.4 of the Company Disclosure
Schedule with which the Company or one of its Subsidiaries has entered into
management services agreements (the "Company P.C.s"), the Company does not own
or have any direct or indirect interest in or control over any corporation,
partnership, joint venture or other entity of any kind.
5.3.5 Financial Statements and Matters. (a) Included in
Section 5.3.5 of the Company Disclosure Schedule are the Company's audited
consolidated balance sheets as at December 31, 1996 and December 31, 1997, and
the audited consolidated statements of operations and cash flows for the
respective fiscal years ended December 31, 1997 and 1996 and the period from
September 19, 1995 (date of inception) to December 31, 1995 as certified by
Price Waterhouse LLP, the independent certified public accountants of the
Company, and the Company's unaudited combined balance sheet as of June 30, 1998
and the related consolidated statements of operations and cash flows for the
six-month period then ended, all of which
23
<PAGE> 27
financial statements (including the footnotes and schedules thereto in the case
of audited statements and subject to information therein noted) were prepared in
accordance with generally accepted accounting principles, consistently applied
during the periods covered thereby, are complete and correct in all material
respects and fairly present the consolidated financial position of the Company
and its Subsidiaries as of the dates of such statements and their consolidated
results of operations for the periods covered thereby (subject, in the case of
unaudited interim financial statements, to year-end adjustments which will not
be material).
(b) The Company's consolidated stockholders' equity (excluding
preferred stock and mandatorily redeemable common stock), cash, working capital
(which does not include any principal amounts owed to PNC Bank which will be
paid off at the Effective Time pursuant to Section 6.1.8) and outstanding
indebtedness (including accrued interest but excluding capital leases) as of
June 30, 1998 are $1,700,209, $969,061, $(8,571,953) and $49,550,914,
respectively.
5.3.6 Absence of Undisclosed Liabilities. Except as disclosed
in Section 5.3.6 of the Company Disclosure Schedule and to the extent reflected
or reserved against in the balance sheet of the Company as of December 31, 1997
included in Section 5.3.5 of the Company Disclosure Schedule (the "Company Base
Balance Sheet"), the Company has no liabilities or obligations of any nature,
whether accrued, absolute, contingent or otherwise, asserted or unasserted,
known or unknown, except liabilities (i) stated or adequately reserved against
on the Company Base Balance Sheet, (ii) incurred in the ordinary course of
business since the date of the Company Base Balance Sheet consistent with the
terms of this Agreement, or (iii) which would not reasonably be expected to have
a Material Adverse Effect on the Company and its Subsidiaries, taken as a whole.
5.3.7 Absence of Certain Developments. Except as set forth in
Section 5.3.7 of the Company Disclosure Schedule and since the date of the
Company Base Balance Sheet, each of the Company and its Subsidiaries and the
Company P.C.s has conducted its business only in the ordinary course consistent
with past practice and there has been: (i) no change in the condition, financial
or otherwise, of the Company and its Subsidiaries and the Company P.C.s taken as
a whole or in the assets, liabilities, properties or business of the Company and
its Subsidiaries, taken as a whole which such change by itself or in conjunction
with all other such changes, whether or not arising in the ordinary course of
business, has had or is reasonably likely to have a Material Adverse Effect on
the Company and its Subsidiaries taken as a whole; (ii) no mortgage, encumbrance
or lien placed on any of the properties of the Company or any of its
Subsidiaries or the Company P.C.s except in the ordinary course consistent with
past practice; (iii) no declaration, setting aside or payment of any dividend or
other distribution with respect to, or any direct or indirect redemption or
acquisition of, any shares of any capital stock of any class of the Company or
any options, warrants or other rights to acquire, or securities convertible into
or exchangeable for, any such capital stock; (iv) no cancellation of any debt or
claim held by the Company or any of its Subsidiaries; (v) no incurrence or
modification by the Company or any of its Subsidiaries of any contingent
liability with respect to the obligations of others, and no incurrence or
modification of any other contingent or fixed obligations or liabilities except
in the
24
<PAGE> 28
ordinary course of business consistent with past practice; (vi) no increase,
direct or indirect, in the compensation paid or payable by the Company, any of
its Subsidiaries or any Company P.C. to any officer, director, employee, agent
or stockholder other than salary increases in the ordinary course of business
consistent with past practice; (vii) no material loss, destruction or damage to
any property of the Company or its Subsidiaries, whether or not insured; (viii)
no notice of any material claim of unfair labor practices or labor dispute or
work stoppage involving the Company, any of its Subsidiaries or any Company
P.C.; (ix) no acquisition or disposition of any assets (or any contract or
arrangement therefor) nor any other transaction by the Company, any of its
Subsidiaries or any Company P.C. other than in the ordinary course of business
consistent with past practice; (x) no payment or discharge of a material lien or
liability of the Company or any of its Subsidiaries which is not recorded in the
latest balance sheet included in Section 5.3.5 of the Company Disclosure
Schedule; (xi) no employment agreements (other than agreements with dentists in
the ordinary course of business consistent with past practice) entered into by
the Company or any of its Subsidiaries or the Company P.C.s and no obligation or
liability incurred by the Company or any of its Subsidiaries or the Company
P.C.s to any of their officers, directors, stockholders or employees, or any
loans or advances made by the Company or any of its Subsidiaries or the Company
P.C.s to any of their officers, directors, stockholders or employees, except
normal compensation and expense allowances payable to officers or employees;
(xii) no material change in accounting methods or practices, credit practices or
collection policies used by the Company, any of its Subsidiaries or any Company
P.C.; and (xiii) no agreement or understanding whether in writing or otherwise,
that would result in any of the transactions or events, or require the Company,
any of its Subsidiaries or the Company P.C.s to take any of the actions,
specified in clauses (i) through (xii) above.
5.3.8 Accounts Receivable. Except as set forth in Section
5.3.8 of the Company Disclosure Schedule and to the extent reserved against in
the Company Base Balance Sheet, all of the accounts receivable of the Company
and its Subsidiaries and the Company P.C.s are valid and enforceable claims, are
subject to no set-off or counterclaim, and are to the knowledge of the Company
collectible in the normal course of business. Except for accounts receivable
from the Company P.C.s or as set forth in Schedule 5.3.8 of the Company
Disclosure Schedule, the Company has no accounts receivable from any person,
firm or corporation which is affiliated with it or from any of its directors,
officers, employees, or stockholders.
5.3.9 Transactions with Affiliates. Except as set forth in
Section 5.3.9 of the Company Disclosure Schedule and except for payments to the
owners of acquired dental practices of accounts receivable collected by the
Company or its subsidiaries on behalf of such owners, there are no loans, leases
or other continuing transactions between the Company or any of its Subsidiaries
or the Company P.C.s and any present or former stockholder of 5% or more of the
outstanding Company Common Stock or other voting securities, director or officer
thereof, or, to the knowledge of the Company, any member of such officer's,
director's or stockholder's immediate family, or any person controlled by such
officer, director or stockholder or his or her immediate family, including
without limitation any transaction that would be discloseable pursuant to Item
404 of SEC Regulation S-K. Except as set forth in Section 5.3.9 of the Company
Disclosure Schedule, no stockholder, director or officer of the Company or any
of its
25
<PAGE> 29
Subsidiaries or the Company P.C.s nor, to the best knowledge of the Company, any
of their respective spouses or family members, owns directly or indirectly on an
individual or joint basis any material interest in, or serves as an officer or
director or in another similar capacity of, any customer or supplier of the
Company or any of its Subsidiaries, or any organization which has a material
contract or arrangement with the Company or any of its Subsidiaries.
5.3.10 Real and Personal Property.
(a) Real Property. Except as set forth in
Section 5.3.10(a) of the Company Disclosure Schedule, neither the Company nor
any of its Subsidiaries owns or has ever owned any real property. All of the
real property leased by the Company, each of its Subsidiaries and each Company
P.C. is identified in Section 5.3.10(a) of the Company Disclosure Schedule
(herein referred to as the "Company Leased Real Property").
(i) Status of Leases. All leases of the
Company Leased Real Property are identified in Section 5.3.10(a) of the
Company Disclosure Schedule, and true and complete copies thereof have
been made available to Monarch. Each of said leases has been duly
authorized and executed by the Company or the Subsidiary of the Company
or the Company P.C. party thereto and, to the knowledge of the Company,
is in full force and effect and constitutes the legal, valid and
binding obligation of the Company or the Subsidiary of the Company or
the Company P.C. party thereto, and is enforceable in accordance with
its respective terms. The Company or the Subsidiary of the Company or
the Company P.C. party thereto has not received notice of any material
default under any of said leases which has not been cured, nor has any
event occurred which, with notice or the passage of time, or both,
would give rise to a default which is reasonably likely to have a
Material Adverse Effect on the Company. To the knowledge of the
Company, the other party to each of said leases is not in default under
any of said leases and there is no event which, with notice or the
passage of time, or both, would give rise to such a default.
(ii) Consents. Except as set forth in
Section 5.3.10(a) of the Company Disclosure Schedule, no consent or
approval is required with respect to the transactions contemplated by
this Agreement from the other parties to any lease of the Company
Leased Real Property.
(iii) Condition of Real Property. Except
as set forth in Section 5.3.10(a) of the Company Disclosure Schedule
and to the knowledge of the Company all premises generally are in good
operating condition and repair, have been well maintained and there are
no material defects in the physical condition of any land, buildings or
improvements constituting part of the Company Leased Real Property that
would result in a material liability of the Company, a Subsidiary of
the Company or a Company P.C. with respect to such Company Leased Real
Property.
26
<PAGE> 30
(iv) Compliance with the Law. None of the Company, any
of its Subsidiaries or any of the Company P.C.s has received any
notice from any governmental authority of any violation of any law,
ordinance, regulation, license, permit or authorization issued with
respect to any Company Leased Real Property that has not been
heretofore corrected and to the knowledge of the Company no such
violation exists, which in either case is reasonably likely to have a
Material Adverse Effect on the operation or value of any Company
Leased Real Property. None of the Company, any of its Subsidiaries or
any of the Company P.C.s has received any notice of any real estate
tax deficiency or assessment or is aware of any proposed deficiency,
claim or assessment with respect to any of the Company Leased Real
Property, or any pending or threatened condemnation thereof.
(b) Personal Property. Except as specifically
disclosed in Section 5.3.10(b) of the Company Disclosure Schedule or in the
Company Base Balance Sheet, the Company, each of its Subsidiaries and each
Company P.C. has good and valid title to all personal property owned by it. To
the knowledge of the Company, none of such personal property or assets is
subject to any mortgage, pledge, lien, conditional sale agreement, security
title, encumbrance or other charge except as specifically disclosed in Section
5.3.10(b) of the Company Disclosure Schedule or in the Company Base Balance
Sheet. The Company Base Balance Sheet reflects all personal property of the
Company and its Subsidiaries. Except as otherwise specified in Section 5.3.10(b)
of the Company Disclosure Schedule, all material items of leasehold
improvements, furnishings, machinery, equipment and other personal property of
any kind or nature of the Company, its Subsidiaries or the Company P.C.s is in
good repair (ordinary wear and tear excepted), has been well maintained, is in
good working order, and substantially complies with all applicable laws,
ordinances and regulations except for any noncompliance therewith which would
not have a Material Adverse Effect on the Company and its Subsidiaries, taken as
a whole.
5.3.11 Tax Matters.
(a) Each of the Company and its Subsidiaries has
filed all federal, state, local and foreign tax returns required to be filed
through the date hereof, and has paid or caused to be paid all federal, state,
local, foreign, and other taxes, including without limitation income taxes,
estimated taxes, excise taxes, sales taxes, use taxes, premium taxes, gross
receipts taxes, franchise taxes, employment and payroll-related taxes,
withholding taxes, stamp taxes, transfer taxes, and property taxes, whether or
not measured in whole or in part by net income (collectively, "Taxes"), required
to be paid through the date hereof whether disputed or not, except taxes which
have not yet accrued or otherwise become due, for which adequate provision has
been made in the pertinent financial statements referred to in Section 5.3.5.
The provisions for taxes on the Company Base Balance Sheet and on the latest
balance sheet included in Section 5.3.5 of the Company Disclosure Schedule are
sufficient as of their respective dates for the payment of all accrued and
unpaid Taxes of any nature of the Company, and any applicable Taxes owing by the
Company to any foreign jurisdiction, whether or not assessed or disputed. All
Taxes and other assessments and levies which the Company is required to withhold
or collect
27
<PAGE> 31
have been withheld and collected and have been paid over to the proper
governmental authorities except where the failure to withhold or collect and pay
over would not be reasonably likely to have a Material Adverse Effect on the
Company and its Subsidiaries, taken as a whole. Neither the Internal Revenue
Service nor any other governmental authority is now asserting or, to the best
knowledge of the Company, threatening to assert against the Company any
deficiency or claim for additional Taxes. Except as set forth in Section 5.3.11
of the Company Disclosure Schedule, neither the Company nor any of its
Subsidiaries has received notice of any audit of any tax return filed by such
person. Except as set forth in Section 5.3.11 of the Company Disclosure
Schedule, no waiver or agreement by the Company is in force for the extension of
time for the assessment or payment of any Taxes. Neither the Company nor any of
its Subsidiaries has received notice of any claim made by an authority in a
jurisdiction where the Company or such Subsidiary does not file tax returns that
the Company or such Subsidiary is or may be subject to taxation by that
jurisdiction. There are no security interests recorded or asserted on any of the
assets of the Company that arose in connection with any failure (or alleged
failure) to pay any Tax.
(b) The Company has made available to Monarch
correct and complete copies of all federal income tax returns, examination
reports, and statements of deficiencies assessed against or agreed to by the
Company or any of its Subsidiaries since the inception of the Company.
(c) Except as set forth in Section 5.3.11(c) of
the Company Disclosure Schedule, neither the Company nor any of its Subsidiaries
has waived any statute of limitations in respect of Taxes or agreed to any
extension of time with respect to a Tax assessment or deficiency.
(d) Neither the Company nor any of its
Subsidiaries has filed a consent under Section 341(f) of the Code concerning
collapsible corporations. Neither the Company nor any of its Subsidiaries has
made any payments, is obligated to make any payments, or is party to any
agreement that under certain circumstances could obligate it to make any
payments that will not be deductible under Section 280G of the Code. Neither the
Company nor any of its Subsidiaries has been a United States real property
holding corporation within the meaning of Section 897(c)(2) of the Code during
the applicable period specified in Section 897(c)(1)(A)(ii) of the Code. Each of
the Company and its Subsidiaries has disclosed on its respective federal income
tax returns all positions taken therein that could give rise to a substantial
understatement of federal income Tax within the meaning of Section 6662 of the
Code. Neither the Company nor any of its Subsidiaries is a party to any Tax
allocation or sharing agreement. Neither the Company nor any of its Subsidiaries
(A) has been a member of an affiliated group filing a consolidated federal
income tax return and (B) has any liability for the Taxes of any Person under
Treasury Regulation Section 1.1502-6 (or any similar provision of state, local,
or foreign law), as a transferee or successor, by contract or otherwise.
28
<PAGE> 32
5.3.12 Contracts and Commitments.
(a) Except as set forth in Section 5.3.12 of the
Company Disclosure Schedule, none of the Company, any of its Subsidiaries or any
Company P.C. is a party to or is otherwise bound by any material (i) employment
contracts; (ii) stock redemption or purchase agreements; (iii) agreements
providing for the indemnification of others against any liabilities or the
sharing of the Tax liability of others; (iv) license agreements (as licensor or
licensee); (v) distributor or sales representative agreements or similar
agreements with any Person (including without limitation employees, marketing
directors or other outside parties) which provide for payment in whole or in
part based on the revenue or net income of the Company, any Subsidiary or any
Company P.C.; (vi) agreements with officers, directors, employees, or
stockholders of the Company, any of its Subsidiaries or any Company P.C.; (vii)
leases of real property other than as disclosed in Section 5.3.10 of the Company
Disclosure Schedule; (viii) agreements with customers of the Company, any
Subsidiary of the Company or any Company P.C.; (ix) plans or contracts providing
for bonuses, pensions, options, stock purchases, deferred compensation,
retirement payments, profit sharing, collective bargaining or the like, or any
contract or agreement with any labor union; (x) agreements for the purchase of
any commodity, material or equipment except purchase orders in the ordinary
course of business consistent with past practice; (xi) agreements containing
covenants limiting the freedom of the Company, any of its Subsidiaries or any
Company P.C. to compete in any line of business or territory or with any Person;
(xii) indentures, mortgages, promissory notes, loan agreements, guaranties or
other agreements or commitments for the borrowing of money or any related
security agreements; (xiii) partnership, trust agreement, joint venture, or
other similar contract, arrangement or agreement; (xiv) registration rights
agreements, warrants, warrant agreements or other rights to subscribe for
securities, any voting agreements, voting trusts, shareholder agreements or
other similar arrangements or any stock purchase or repurchase agreements or
stock restriction agreements; (xv) contract, agreement or other arrangement with
any governmental authority, insurance company, third-party fiscal intermediary
or carrier administering any Medicaid program of any state, the Medicare
program, any clinic or other in-patient health care facility, dental health or
health maintenance organization, preferred provider organization, dental
insurance company, managed dental care plan or other dental benefits provider,
self-insured employer or other third-party payor of any kind or nature; (xvi)
agreement providing for the payment of dental services provided to the patients
of any Company P.C. on credit or any other financing arrangement with the
patients of any Company P.C.; or (xvii) other agreement, contract or commitment
which provides for or involves payments by or imposes any liability or
obligation on the Company, any of its Subsidiaries or any Company P.C. in excess
of $50,000.
(b) To the knowledge of the Company, all
contracts, agreements, leases and instruments to which the Company, any of its
Subsidiaries or any Company P.C. is a party or by which any such entity is
obligated have been duly authorized by the Company or the applicable Subsidiary
of the Company or Company P.C., and, to the knowledge of the Company, are valid
and are in full force and effect and constitute legal, valid and binding
obligations of such entity, and, to the knowledge of the Company, are
enforceable in accordance with their respective terms, in each case, except to
the extent that enforceability may be limited by
29
<PAGE> 33
applicable bankruptcy, insolvency or similar laws affecting the enforcement of
creditors' rights generally and subject to general principles of equity. The
Company does not know of any notice or threat of or basis for the termination,
expiration or modification of any such agreements within one year from the date
hereof, which termination, expiration or modification is reasonably likely to
have a Material Adverse Effect on the Company and its Subsidiaries, taken as a
whole. Neither the Company nor, to the knowledge of the Company, any other party
to any material contract, agreement or instrument of the Company, any of its
Subsidiaries or any Company P.C., is in default in complying with any provisions
thereof, and no condition or event or fact exists which, with notice, lapse of
time or both would constitute a default thereunder on the part of the Company or
the applicable Subsidiary of the Company or any Company P.C., or, to the best
knowledge of the Company, any other party thereto, except for any such default,
condition, event or fact that, individually or in the aggregate, would not be
reasonably likely to have a Material Adverse Effect on the Company and its
Subsidiaries, taken as a whole.
(c) Except as disclosed in Section 5.3.12 of the
Company Disclosure Schedule, none of the Company, any of its Subsidiaries or any
Company P.C. (i) has any liability for renegotiation of government contracts or
subcontracts, (ii) has been suspended or barred from bidding on contracts or
subcontracts with any federal, state or local agency or governmental authority,
(iii) has been audited or investigated by any such agency or authority with
respect to contracts entered into or goods and services provided by the Company
or the applicable Subsidiary of the Company or any Company P.C. or (iv) has had
a contract terminated by any such agency or authority for default or failure to
perform in accordance with applicable standards.
5.3.13 Intellectual Property Rights; Employee Restrictions.
Except as set forth in Section 5.3.13 of the Company Disclosure Schedule, each
of the Company, its Subsidiaries and the Company P.C.s (i) has exclusive
ownership of or an exclusive license or other rights to use its trademarks,
trademark applications, service marks, service mark applications, trade names,
copyrights, trade secrets, product designs and systems set forth in Section
5.3.13 of the Company Disclosure Schedule and (ii) owns or has a valid license
or other rights to use its computer software listed in Section 5.3.13 of the
Company Disclosure Schedule (the "Software") and all other patents, patent
applications, trademarks, trademark applications, service marks, service mark
applications, trade names, copyrights, manufacturing processes and trade secrets
(collectively "Intellectual Property") material in the conduct of its business
as presently conducted and as proposed to be conducted. To the best knowledge of
the Company, there are no infringements by any other person of any rights of the
Company, its Subsidiaries and the Company P.C.s under any such Intellectual
Property. No claim is pending or, to the knowledge of the Company, threatened
against the Company, any of its Subsidiaries or any Company P.C. to the effect
that any such Intellectual Property infringes upon or conflicts with the
asserted rights of any other person and, to the knowledge of the Company, there
is no basis for any such claim (whether or not pending or threatened).
30
<PAGE> 34
5.3.14 Litigation. Except as disclosed in Section 5.3.14 of
the Company Disclosure Schedule, there is no litigation or governmental or
administrative proceeding or investigation pending or, to the knowledge of the
Company, threatened against the Company, any of its Subsidiaries or any Company
P.C. or affecting any of their respective properties or assets, or against any
of their respective officers, directors, stockholders, professional employees or
other key employees, or which may call into question the validity or hinder the
enforceability or performance of this Agreement or the agreements and
transactions contemplated hereby which, if decided adversely, would be
reasonably likely to have a Material Adverse Effect on the Company and its
Subsidiaries, taken as a whole; nor, to the knowledge of the Company, has there
occurred any event nor does there exist any condition or state of facts on the
basis of which any such claim may be asserted. To the knowledge of the Company,
no claim has been asserted against the Company, any of its Subsidiaries or any
Company P.C. for renegotiation or price redetermination of any business
transaction. Section 5.3.14 of the Company Disclosure Schedule sets forth a
summary of all material litigation involving (i) the Company since inception,
(ii) its Subsidiaries since inception if formed by the Company, or since the
Company's acquisition thereof, or (iii) any Company P.C. since inception if
established at the request of the Company, or, in all other cases, since the
date of affiliation with the Company.
5.3.15 Permits; Compliance with Laws.
(a) Except as disclosed in Section 5.3.15 of the
Company Disclosure Schedule, the Company, each of its Subsidiaries and each
Company P.C. has all material Permits required in connection with the ownership
of its properties and the conduct of its business as the same is presently
conducted and all such Permits are valid and in full force and effect. No Permit
is subject to termination as a result of the execution of this Agreement or
consummation of the transactions contemplated hereby. Except as disclosed in
Section 5.3.15 of the Company Disclosure Schedule, the Company, each of its
Subsidiaries and each Company P.C. is now and has heretofore been in compliance
with all applicable statutes, ordinances, orders, rules and regulations
(including all applicable dental practice, OSHA, consumer credit and
environmental laws and regulations) promulgated by any federal, state, municipal
or other governmental authority which apply to the conduct of its business other
than such non-compliance as would not be reasonably expected to have a Material
Adverse Effect on the Company and its Subsidiaries, taken as a whole. Except as
set forth in Section 5.3.15(a) of the Company Disclosure Schedule, none of the
Company, any of its Subsidiaries or any Company P.C. has ever entered into or
been subject to any judgment, consent decree, compliance order or administrative
order with respect to any environmental or health and safety law or received any
request for information, notice, demand letter, administrative inquiry or formal
or informal complaint or claim with respect to any environmental or health and
safety matter or the enforcement of any such law.
(b) Each employee of the Company, each
Subsidiary of the Company and each Company P.C. who provides dental health care
services (each a "Health Care Provider") is duly licensed or registered under
the laws of the jurisdiction or jurisdictions in which such Health Care Provider
provides such services, and each Health Care Provider has complied in all
material respects with all laws, rules and regulations relating to the rendering
of
31
<PAGE> 35
services including, without limitation, the Occupational Safety and Health Act
and the rules promulgated thereunder. Except as set forth in Section 5.3.15 of
the Company Disclosure Schedule, no Health Care Provider since his or her
affiliation with the Company, any of its Subsidiaries or any of the Company
P.C.s (in the case of the Subsidiaries of the Company and the Company P.C.s,
since the date of their affiliation with the Company): (i) has had his or her
professional license or registration, Drug Enforcement Agency number, Medicare
or Medicaid provider status, or staff privileges at any hospital or dental
facility suspended, relinquished, terminated or revoked, (ii) has been
reprimanded, sanctioned or disciplined by any licensing board or any federal,
state or local society, agency, regulatory body, governmental authority,
hospital, third-party payor or speciality board; or (iii) has had a final
judgment or settlement entered against him or her in connection with a
malpractice or similar action. The names of the Health Care Providers who
provide services in connection with the business of the Company, its
Subsidiaries and the Company P.C.s are set forth in Section 5.3.15 of the
Company Disclosure Schedule. None of the Company, any Subsidiary of the Company
or, to the knowledge of the Company, any Company P.C. has received notice of any
claim alleging that, and the Company has no knowledge that, any of the employed
and engaged Company Health Care Providers uses (without a physician's approval)
or abuses any controlled substances or is or was under the influence of alcohol
or is or was affected by the use of alcohol, in each case during the performance
of his or her duties and obligations under any contracts, agreements or
understandings with the Company, any of its Subsidiaries or any Company P.C.
including as an employee of a Company P.C.
(c) None of the Company, any of its Subsidiaries
or any Company P.C. is required to make material filings under any insurance
holding company or similar state statute, or to be licensed or authorized as an
insurance holding company in any jurisdiction in order to conduct its business
as presently conducted. The dental services and related products offered and
provided by the Company P.C.s have been and are offered and provided in
compliance with the requirements of all relevant laws and regulations
(including, without limitation, consumer credit or similar laws relating to the
extension of credit or other financing by the Company, any of its Subsidiaries
or any Company P.C. to patients receiving services of the Company P.C.s), except
for any non-compliance not having a Material Adverse Effect on the Company and
its Subsidiaries, taken as a whole, and none of the Company, any of its
Subsidiaries or any Company P.C. has received any notification from any
governmental regulatory authority to the effect that any Permit from such
regulatory authority is needed to be obtained by it in order to conduct its
business which has not been duly obtained. Except as set forth in Section 5.3.15
of the Company Disclosure Schedule, none of the Company, any Subsidiary of the
Company or any Company P.C. receives reimbursement from any Medicare or Medicaid
program.
(d) The Company is not aware of any legislation,
rule or regulation which shall either (i) have been proposed and be in its
reasonable judgment reasonably likely to be adopted in any of the states in
which it presently conducts operations, in the foreseeable future, or (ii) have
been adopted in any of the states in which it presently conducts operations in
either case that, individually or in the aggregate, has a Material Adverse
Effect or could
32
<PAGE> 36
reasonably be anticipated to have a Material Adverse Effect on the Company and
its Subsidiaries, taken as a whole.
5.3.16 Labor Laws. As of June 18, 1998, the Company, its
Subsidiaries and the Company P.C.s employ the number of full-time and part-time
employees and the number of dentists as are indicated in Section 5.3.16 of the
Company Disclosure Schedule, which also sets forth the non-competition terms
applicable to each former owner of a practice which the Company acquired. None
of the Company, any of its Subsidiaries or any Company P.C. is delinquent in
payments to any of its employees or agents for any wages, salaries, commissions,
bonuses or other direct compensation for any services performed for it to the
date hereof or amounts required to be reimbursed to such employees. There are no
charges of employment discrimination or unfair labor practices or strikes,
slowdowns, stoppages of work, or any other concerted interference with normal
operations existing, pending or, to the knowledge of the Company, threatened
against or involving the Company, any of its Subsidiaries or any Company P.C. No
question concerning representation exists respecting any group of employees of
the Company, any of its Subsidiaries or any Company P.C. Except as set forth in
Section 5.3.16 of the Company Disclosure Schedule, there are no claims or
charges relating to or alleging violations of any federal, state or local
employment laws, including, without limitation, laws relating to discrimination,
harassment, family leave or wage payments, existing, pending or, to the
knowledge of the Company, threatened against the Company, any of its
Subsidiaries or any Company P.C. nor, to the knowledge of the Company, has there
occurred any event or does there exist any condition on the basis of which any
such claim is reasonably likely to be asserted. The Company, each of its
Subsidiaries and each Company P.C. is, and at all times since November 6, 1986
has been, in compliance in all material respects with the requirements of the
Immigration Reform Control Act of 1986. Except as set forth in Schedule 5.3.16,
there are no changes (including, without limitation, resignations) pending or,
to the knowledge of the Company, threatened with respect to the senior
management, key supervisory personnel or dentists of the Company, any of its
Subsidiaries or any Company P.C. nor has the Company, any of its Subsidiaries or
any Company P.C. received any notice or information concerning any prospective
change with respect to the senior management, key supervisory personnel or
dentists of the Company, any of its Subsidiaries or any Company P.C.
5.3.17 Information Supplied to Monarch. No statement made in
writing or other written information furnished by the Company to Monarch or its
representatives (including, but not limited to, the Financial Statements, all
information in the Company Disclosure Schedule and the other Exhibits and
Schedules hereto and the Registration Statement of the Company on Form S-1 (File
No. 333-38731) and the amendments thereto filed through the date hereof) or any
other documents delivered in connection with the transactions contemplated by
this Agreement, contains any untrue statement of a material fact or omits to
state a material fact necessary in order to make the statements so made or
information so delivered not misleading.
33
<PAGE> 37
5.3.18 Employee Benefit Programs.
(a) Section 5.3.18 of the Company Disclosure Schedule
sets forth a list of every Employee Program currently maintained by the Company,
any of its Subsidiaries or any Company P.C.
(b) Each Employee Program which has been maintained
by the Company, any of its Subsidiaries or any Company P.C. and which has at any
time been intended to qualify under Section 401(a) or 501(c)(9) of the Code, has
received a favorable determination or approval letter from the IRS regarding its
qualification under such section and has, in fact, been qualified under the
applicable section of the Code from the effective date of such Employee Program
through and including the Effective Time (or, if earlier, the date that all of
such Employee Program's assets were distributed). Except for amendments made to
the Code for which the remedial amendment period has not expired, no event or
omission has occurred which would cause any such Employee Program to lose its
qualification under the applicable Code section.
(c) There has not been any failure of any party to
comply with any laws applicable with respect to the Employee Programs that have
been maintained by the Company, its Subsidiaries or any Company P.C. which is
reasonably likely to have a Material Adverse Effect on the Company and its
Subsidiaries, taken as a whole. With respect to any Employee Program now or
heretofore maintained by the Company, any of its Subsidiaries or any Company
P.C., there has occurred no "prohibited transaction," as defined in Section 406
of the Employee Retirement Income Security Act of 1974, as amended ("ERISA"), or
Section 4975 of the Code, or breach of any duty under ERISA or other applicable
law (including, without limitation, any health care continuation requirements or
any other tax law requirements, or conditions to favorable tax treatment,
applicable to such plan), which could result, directly or indirectly (including
without limitation through any obligation of indemnification or contribution),
in any taxes, penalties or other liability to the Company or any Affiliate (as
defined below) which is reasonably likely to have a Material Adverse Effect on
the Company and its Subsidiaries, taken as a whole. No litigation, arbitration,
or governmental administrative proceeding (or investigation) or other proceeding
(other than those relating to routine claims for benefits) is pending or, to the
knowledge of the Company, threatened with respect to any such Employee Program
which is reasonably likely to have a Material Adverse Effect on the Company and
its Subsidiaries, taken as a whole.
(d) None of the Company, any of its Subsidiaries or
any Company P.C. has incurred any liability under Title IV of ERISA which will
not be paid in full prior to the Effective Time. There has been no "accumulated
funding deficiency" (whether or not waived) with respect to any Employee Program
ever maintained by the Company, any of its Subsidiaries or any Company P.C.s and
subject to Code Section 412 or ERISA Section 302. With respect to any Employee
Program maintained by the Company, any of its Subsidiaries or any Company P.C.
and subject to Title IV of ERISA, there has been no (nor will there be any as a
result of the transaction contemplated by this Agreement) (i) "reportable
event," within the meaning of
34
<PAGE> 38
ERISA Section 4043, or the regulations thereunder (for which the notice
requirement is not waived under 29 C.F.R. Part 2615) and (ii) event or condition
which presents a material risk of plan termination or any other event that may
cause the Company, any of its Subsidiaries or any Company P.C. to incur
liability or have a lien imposed on its assets under Title IV of ERISA. All
payments and/or contributions required to have been made (under the provisions
of any agreements or other governing documents or applicable law) with respect
to all Employee Programs heretofore maintained by the Company, any of its
Subsidiaries or any Company P.C., for all periods prior to the Effective Time,
either have been made or have been accrued (and all such unpaid but accrued
amounts are described on Section 5.3.18 of the Company Disclosure Schedule).
Except as described in Section 5.3.18 of the Company Disclosure Schedule, no
Employee Program maintained by the Company, any of its Subsidiaries or any
Company P.C. and subject to Title IV of ERISA (other than a Multiemployer Plan)
has any "unfunded benefit liabilities" within the meaning of ERISA Section
4001(a)(18), as of the Closing Date. None of the Company, any of its
Subsidiaries or any Company P.C. has ever maintained a Multiemployer Plan. None
of the Employee Programs ever maintained by the Company, any of its Subsidiaries
or any Company P.C. has ever provided health care or any other non-pension
benefits to any employees after their employment was terminated (other than as
required by part 6 of subtitle B of title I of ERISA) or has ever promised to
provide such post-termination benefits.
(e) With respect to each Employee Program maintained
by the Company, any of its Subsidiaries or any Company P.C. within the three
years preceding the date hereof, complete and correct copies of the following
documents (if applicable to such Employee Program) have previously been
delivered to the Company: (i) all documents embodying or governing such Employee
Program, and any funding medium for the Employee Program (including, without
limitation, trust agreements) as they may have been amended to the date hereof;
(ii) the most recent IRS determination or approval letter with respect to such
Employee Program under Code Section 401 or 501(c)(9), or any applications for
determination or approval filed with the IRS; (iii) the three most recently
filed IRS Forms 5500, with all applicable schedules and accountants' opinions
attached thereto; (iv) the summary plan description for such Employee Program
(or other written descriptions of such Employee Program provided to employees)
and all modifications thereto; (v) any insurance policy (including any fiduciary
liability insurance policy) related to such Employee Program; and (vi) any
documents evidencing any loan to an Employee Program that is a leveraged
employee stock ownership plan.
(f) Except as set forth in Section 5.3.18 of the
Company Disclosure Schedule, each Employee Program maintained by the Company as
of the date hereof is subject to termination by the Board of Directors of the
Company without any further liability or obligation on the part of the Company
to make further contributions to any trust maintained under any such Employee
Program following such termination other than with respect to contributions or
benefits accrued through the date of termination.
5.3.19 Environmental Matters, Hazardous Waste, Etc. No
hazardous wastes, substances or materials or oil or petroleum products have been
generated, transported, used, disposed, stored or treated by the Company, any of
its Subsidiaries or any Company P.C. and no
35
<PAGE> 39
hazardous wastes, substances or materials, or oil or petroleum products have
been released, discharged, disposed, transported, placed or otherwise caused to
enter the soil or water in, under or upon any real property owned, leased or
operated by the Company, any of its Subsidiaries or any Company P.C., in each
case in violation of any applicable federal, state or local law, regulation,
rule or order which violation remains uncorrected.
5.3.20 Insurance. The physical properties, assets, business,
operations, employees, officers and directors of the Company, its Subsidiaries
and the Company P.C.s are insured to the extent disclosed in Section 5.3.20 of
the Company Disclosure Schedule. There is no claim by the Company, any of its
Subsidiaries or any Company P.C. pending under any such policies as to which
coverage has been questioned, denied or disputed by the insurer. Said insurance
policies and arrangements are in full force and effect, all premiums with
respect thereto are currently paid, and the Company, its Subsidiaries and the
Company P.C.s are in compliance in all material respects with the terms thereof.
The professional malpractice insurance coverage of the Company, its Subsidiaries
and the Company P.C.s complies in all material respects with all requirements of
applicable law and the Company, its Subsidiaries and the Company P.C.s have
obtained the necessary insurance coverage to comply with all material agreements
and leases to which any of them is a party. Except as set forth in Schedule
5.3.20, each such insurance policy shall continue to be in full force and effect
following consummation of the transactions contemplated by this Agreement.
5.3.21 Relationship with Customers and Plans. Section 5.3.21
of the Company Disclosure Schedule lists all managers, employees, consultants
and independent contractors (including dentists and related professional
corporations and the current job title and aggregate annual compensation of such
individual) of the Company, any of its Subsidiaries or any Company P.C. who have
individually received for the fiscal year ended December 31, 1997, or are
scheduled to receive for the fiscal year ending December 31, 1998, compensation
or payments in excess of $50,000. No dental insurance plan, managed care plan or
similar plan which accounted for more than 5% of the consolidated revenues of
the Company for the fiscal year ended December 31, 1997 or which is otherwise
significant to the Company has canceled or otherwise terminated its relationship
with the Company or any of the Company P.C.s, or has during said period
decreased materially its usage or purchase of the services or products of the
Company, any of its Subsidiaries or any of the Company P.C.s. Section 5.3.21 of
the Company Disclosure Schedule lists all the suppliers to whom the Company, any
of its Subsidiaries or any of the Company P.C.s made payments aggregating in
excess of $50,000 during the fiscal year ended December 31, 1997, including the
aggregate amount of such payments. No such plan or supplier has, to the
knowledge of the Company, any plan or intention to terminate, to cancel or
otherwise materially and adversely modify its relationship with the Company, any
of its Subsidiaries or any of the Company P.C.s, nor has the Company received
any notice or information concerning the foregoing.
5.3.22 Absence of Questionable Payments. Neither the Company
or any of its Subsidiaries, nor to the knowledge of the Company, any director,
officer, agent, employee or other Person acting on behalf of the Company or any
of its Subsidiaries, has used any funds of
36
<PAGE> 40
the Company or any of its Subsidiaries for unlawful contributions, payments,
gifts or entertainment, or made any unlawful expenditures relating to political
activity to domestic or foreign government officials or others. The Company has
adequate financial controls to prevent such improper or unlawful contributions,
payments, gifts, entertainment or expenditures. None of the Company or any of
its Subsidiaries, or to the knowledge of the Company, any current director,
officer, agent, employee or other Person acting on behalf of the Company or any
of its Subsidiaries, has accepted or received any unlawful contributions,
payments, gifts or expenditures. Each of the Company and its Subsidiaries has at
all times complied, and is in compliance, in all respects with the U.S. Foreign
Corrupt Practices Act and all foreign laws and regulations relating to
prevention of corrupt practices and similar matters.
5.3.23 Investment Banking; Brokerage. Except as set forth in
Section 5.3.23 of the Company Disclosure Schedule, there are no claims for
investment banking fees, brokerage commissions, finder's fees or similar
compensation (exclusive of professional fees of lawyers and accountants) in
connection with the transactions contemplated by this Agreement based on any
arrangement or agreement made by or on behalf of the Company or any Subsidiary
of the Company.
5.3.24 Hart-Scott-Rodino Act. Under 15 U.S.C. Section 18a and
the regulations promulgated thereunder, (i) the Company is not, and at the
Effective Time the Company will not be, a "person" which has total assets or
annual net sales of $100,000,000 or more and (ii) no Person other than the
Company is the Company's "ultimate parent entity".
5.3.25 Certain Provisions. Except as disclosed in this
Agreement or in the Company Disclosure Schedule, the consummation of the
transactions contemplated by this Agreement will not trigger or otherwise result
in any obligation on the part of Monarch or the Surviving Corporation, and
neither Monarch nor the Surviving Corporation will have to pay to any
Stockholder of the Company any amount in excess of the Merger Consideration and
those amounts in connection with the contingent payments referred to in Section
5.3.6 of the Company Disclosure Schedule, provided that it is understood that
the number of shares of Company Common Stock to be issued in the Mazza
transaction referred to in such Disclosure Schedule is based on a market price
assumption and the number of shares to be issued could be greater or less based
upon the market price of Monarch's Common Stock.
ARTICLE VI
CONDITIONS
6.1 CONDITIONS TO THE OBLIGATIONS OF THE COMPANY. The obligations of
the Company to consummate the Merger are subject to the fulfillment at or prior
to the Effective Time of the following conditions, any or all of which may be
waived in whole or in part by the Company to the extent permitted by applicable
law.
6.1.1 CERTIFICATE. The representations and warranties of
Monarch set forth in this Agreement shall be true and correct in all material
respects on and as of the Effective
37
<PAGE> 41
Time with the same force and effect as though the same had been made on and as
of the Effective Time. Monarch shall have performed in all material respects all
of its obligations under this Agreement theretofore to be performed, and the
Company shall have received at the Effective Time a certificate to that effect
dated the Effective Time and executed by the Chief Executive Officer or Chief
Financial Officer of Monarch.
6.1.2 STOCKHOLDER APPROVAL. This Agreement shall have been
duly approved by the holders of a majority of the outstanding shares of common
stock of the Company at a stockholder meeting or by written consent in lieu
thereof, in accordance with applicable law and the Certificate of Incorporation
and By-Laws of the Company.
6.1.3 OPINION OF COUNSEL AND OTHER DOCUMENTS. On the Closing
Date, the Company and the Principal Stockholders shall have received (i) an
opinion of counsel for Monarch dated as of the Closing Date and addressed to the
Company and the Principal Stockholders, substantially in the form attached as
Exhibit 6.1.3 hereto, and (ii) such other certificates and documents with
respect to Monarch and Merger Sub as counsel for the Company and the Principal
Stockholders shall have reasonably requested.
6.1.4 [RESERVED].
6.1.5 GOVERNMENTAL FILINGS AND CONSENTS. All governmental
filings required to be made prior to the Effective Time by the Company and
Monarch with, and all governmental consents required to be obtained prior to the
Effective Time from, governmental and regulatory authorities in connection with
the execution and delivery of this Agreement and the consummation of the
transactions contemplated hereby shall have been made or obtained, except where
the failure to make such filing or obtain such consent would not reasonably be
expected to have a Material Adverse Effect with respect to the Surviving
Corporation (assuming the Merger had taken place). There shall be in effect no
preliminary or permanent injunction or other order of a court or governmental or
regulatory agency of competent jurisdiction directing that the transactions
contemplated herein not be consummated.
6.1.6 THIRD-PARTY CONSENTS. All required authorizations,
consents and approvals of any Person (other than a governmental authority)
required to be obtained by the Company or Monarch in connection with the
transactions contemplated hereby, the failure of which to obtain would have a
Material Adverse Effect with respect to the Surviving Corporation (assuming the
Merger had taken place), shall have been obtained.
6.1.7 CERTAIN DOCUMENTS. Monarch shall have executed and
delivered:
(i) a Registration Rights Agreement in
substantially the form attached as Exhibit 6.1.7(a) (the "Registration Rights
Agreement");
(ii) the Escrow Agreement in substantially
the form attached as Exhibit 4.4 (the "Escrow Agreement");
38
<PAGE> 42
(iii) option agreements relating to 350,000
shares of Monarch common stock as contemplated by Section 8.15; and
(iv) an Employment Agreement by and between
Joseph J. Frank and Monarch in substantially the form attached as Exhibit
6.1.7(b) (the "Employment Agreement').
6.1.8 PAY-OFF OF PNC DEBT. At the Effective Time , Monarch
shall have (i) paid off and satisfied the entire amount of principal of and
interest on the Company's discretionary line of credit with PNC Bank, National
Association (the "Bank") which amount is $11,757,796.38 and (ii) caused the
guarantees by the Principal Stockholders of such line of credit to be released
by the Bank.
6.1.9 PAY-OFF OF PRINCIPAL STOCKHOLDER DEBT. At the Effective
Time, Monarch shall have, subject to execution of corresponding pay-off letters
and releases, paid off the outstanding amount of principal of and interest due
to the Principal Stockholders (the "Foster Debt") under those certain 9%
subordinated promissory notes issued by the Company, which aggregate amount is
$21,265,551 after the contribution to the capital of the Company and release
occurring simultaneously with the Closing as contemplated by Section 6.2.8.
6.1.10 PAYMENT OF EXPENSES AND LIABILITIES. At the Effective
Time, the Surviving Corporation shall pay all expenses referred to in Section
8.1 and the liabilities of the Company listed in Section 6.1.10 of the Company
Disclosure Schedule.
6.2 CONDITIONS TO THE OBLIGATIONS OF MONARCH. The obligation of Monarch
to consummate the Merger is subject to the fulfillment at or prior to the
Effective Time of the following conditions, any or all of which may be waived in
whole or in part by Monarch to the extent permitted by applicable law.
6.2.1 CERTIFICATES. The representations and warranties of the
Company and the Principal Stockholders set forth in this Agreement shall be true
and correct in all material respects on and as of the Effective Time with the
same force and effect as though the same had been made on and as of the
Effective Time , the Company and the Principal Stockholders shall have performed
in all material respects all of their respective obligations under this
Agreement theretofore to be performed, and Monarch shall have received at the
Effective Time certificates to that effect dated the Effective Time and executed
by the Chief Executive Officer or President of the Company and the general
partner of each of the Principal Stockholders.
6.2.2 NO LITIGATION. There shall not be pending or threatened
by any governmental authority or regulatory agency, any suit, action or
proceeding, (A) challenging or seeking to restrain or prohibit the Merger or any
of the other transactions contemplated by this Agreement or seeking to obtain
from the Company or Monarch or any of their respective Subsidiaries in
connection with the Merger any material damages, (B) seeking to prohibit or
limit the ownership or operation by the Company or Monarch or any of their
respective Subsidiaries of
39
<PAGE> 43
any material portion of the business or assets of the Company or Monarch or any
of their respective Subsidiaries, or to compel the Company, Monarch or any of
their respective Subsidiaries to dispose of or hold separate any material
portion of the business or assets of the Company, Monarch or any of their
respective Subsidiaries in each case as a result of the Merger or any of the
other transactions contemplated by this Agreement, or (C) which otherwise is
reasonably likely to have a Material Adverse Effect with respect to Monarch and
its Subsidiaries or the Company and its Subsidiaries, in each case, taken as a
whole. There shall be in effect no preliminary or permanent injunction or other
order of a court or governmental or regulatory agency of competent jurisdiction
directing that the transactions contemplated herein not be consummated.
6.2.3 OPINION OF COUNSEL AND OTHER DOCUMENTS. On the Closing
Date, Monarch shall have received (i) opinions of counsel for the Company and
the Principal Stockholders, dated as of the Closing Date and addressed to
Monarch, substantially in the form attached as Exhibit 6.2.3 hereto and (ii)
such other certificates and documents as counsel to Monarch shall have
reasonably requested from the Company and the Principal Stockholders.
6.2.4 [RESERVED]
6.2.5 GOVERNMENTAL FILINGS AND CONSENTS. All governmental
filings required to be made prior to the Effective Time by the Company and
Monarch with, and all governmental consents required to be obtained prior to the
Effective Time from, governmental and regulatory authorities in connection with
the execution and delivery of this Agreement and the consummation of the
transactions contemplated hereby shall have been made or obtained, except where
the failure to make such filing or obtain such consent would not reasonably be
expected to have a Material Adverse Effect with respect to the Surviving
Corporation (assuming the Merger had taken place).
6.2.6 THIRD-PARTY CONSENTS. All required authorizations,
consents and approvals of any Person (other than a governmental authority)
required to be obtained by the Company or Monarch in connection with the
transactions contemplated hereby, the failure of which to obtain would have a
Material Adverse Effect with respect to the Surviving Corporation (assuming the
Merger had taken place), shall have been obtained.
6.2.7 CERTAIN DOCUMENTS. Monarch shall have received executed
copies of:
(i) the Registration Rights Agreement,
with other such stockholders of the Company to become parties to the same by
execution of a Letter of Transmittal;
(ii) Letters of Transmittal signed by each
of the Principal Stockholders including a general release of claims (other than
those arising in connection with
40
<PAGE> 44
the transactions contemplated hereby) in substantially the form attached hereto
as Exhibit 6.2.7(ii);
(iii) the Escrow Agreement; and
(iv) the Employment Agreement.
6.2.8 COMPANY INDEBTEDNESS; NET WORTH; WORKING CAPITAL. The
Principal Stockholders shall have contributed to the capital of the Company and
released indebtedness represented by the 9% Promissory Notes owed by the Company
in the amount of $11,002,739 and shall have canceled the redeemable preferred
stock and accrued dividends thereon in the amount of $997,261, the Company's
outstanding indebtedness (including accrued interest but not including capital
leases) after such contribution of capital shall not be greater than
$43,000,000, and as of June 30, 1998, the Company had stockholders' equity
(excluding preferred stock and mandatorily redeemable common stock) of
$1,700,209 and working capital of $(8,571,953), and the Chief Executive Officer
and Chief Financial Officer of the Company shall have delivered a certificate to
such effect to Monarch.
ARTICLE VII
SURVIVAL; INDEMNIFICATION
7.1 SURVIVAL OF REPRESENTATIONS, WARRANTIES, ETC. All representations,
warranties, agreements, covenants and obligations herein or in any schedule or
certificate delivered by any party incident to the closing of the transactions
contemplated hereby are material and may be relied upon by the party receiving
the same and shall survive the Closing regardless of any investigation by such
party and shall not merge into the performance of any obligation by any party
hereto, subject to the provisions of this Article VII, for a period of fifteen
(15) months after the Closing Date except for covenants and agreements to be
performed subsequent to Closing and except for matters described in Section
7.3.3.
7.2 INDEMNIFICATION BY THE PRINCIPAL STOCKHOLDERS AND MANAGEMENT
STOCKHOLDERS. The Principal Stockholders and the Management Stockholders jointly
and severally agree, in all cases subject to the limitations set forth in this
Article VII, subsequent to the Closing Date to indemnify and hold harmless
Monarch and the Surviving Corporation (in either case, the "Monarch Indemnified
Party") from and against and in respect of all losses, liabilities, obligations,
damages, deficiencies, actions, suits, proceedings, demands, assessments,
orders, judgments, fines, penalties, costs and reasonable expenses (including
the reasonable fees, disbursements and expenses of attorneys, accountants and
consultants) of any kind or nature whatsoever (whether or not arising out of
third-party claims and including all amounts paid in investigation, defense or
settlement of the foregoing) (a "Loss" or "Losses") sustained, suffered or
incurred by or made against the Monarch Indemnified Party, as the same are
incurred, arising out of or based upon: (a) any breach or inaccuracy of any
representation or warranty made by the Company or the Principal Stockholders
pursuant to Section 5.1 or 5.3 of this Agreement (provided that with respect to
the representations and
41
<PAGE> 45
warranties made in Section 5.1, each Principal Stockholder shall severally and
not jointly indemnify the Monarch Indemnified Parties for any breach or
inaccuracy of such representations and warranties made by such Principal
Stockholder; (b) any breach of any covenant or agreement made by the Company or
any Principal Stockholder in this Agreement or in any Schedule hereto; or (c)
liabilities relating to Losses with respect to the matters set forth on Schedule
7.2(c) attached hereto (claims under clauses (a) through (c) hereinafter
collectively referred to as "Monarch Indemnifiable Losses"). Indemnification
under this Section 7.2 shall be payable as set forth in Section 7.4.
7.3 LIMITATIONS ON INDEMNIFICATION BY THE PRINCIPAL STOCKHOLDERS
AND MANAGEMENT STOCKHOLDERS.
7.3.1 General Threshold. Subject to the exceptions set forth
in Section 7.3.3, the Principal Stockholders and Management Stockholders shall
not be obligated to indemnify the Monarch Indemnified Party in respect of
Monarch Indemnifiable Losses except to the extent the cumulative amount of all
Monarch Indemnifiable Losses exceeds $250,000 (the "Monarch Threshold"), which
excess cumulative amount shall be recoverable in accordance with the terms
hereof.
7.3.2 Time Limits for Claims. Subject to the exceptions set
forth in Section 7.3.3, no claim for indemnification may be made by any Monarch
Indemnified Party in respect of Monarch Indemnifiable Losses unless the written
notice required by Section 7.8 with respect to such Losses shall have been
received by the Representative (as defined below) on a date prior to the date
that is fifteen months after the Closing Date; provided, however, that if prior
to the applicable date of expiration a specific state of facts shall have become
known which may constitute or give rise to any Monarch Indemnifiable Loss as to
which indemnity may be payable and the Monarch Indemnified Party shall have
given notice of such facts to the Representative as contemplated by Section 7.8,
made a claim for indemnification and, except with respect to third party claims,
pursued such claim within three months thereafter, then the right to
indemnification with respect thereto shall remain in effect until such matter
shall have been finally determined and disposed of, and any indemnification due
in respect thereof shall have been paid.
7.3.3 Dollar-for-Dollar Claims. Notwithstanding anything
herein to the contrary, the Monarch Indemnified Party shall not be subject to
any limitation under Section 7.3, and shall be entitled to dollar-for-dollar
recovery, in seeking indemnification from the Principal Stockholders with
respect to the following:
(a) Losses arising from fraud or an intentional
misrepresentation on the part of any Principal Stockholder or the
Company;
(b) Losses arising from breach of a covenant by
the Company or any Principal Stockholder;
42
<PAGE> 46
(c) Losses involving a breach or inaccuracy of
the representations and warranties contained in Section 5.1 and
Sections 5.3.3, 5.3.5(b), 5.3.9, 5.3.23, 5.3.24, or 8.1; or
(d) Losses described in Section 7.2 (c).
7.3.4 Stockholder Representative. Each Principal Stockholder
and each Management Stockholder hereby irrevocably appoints Foster Management
Company as his, her or its representative (the "Representative") for all matters
relating to this Agreement and the transactions contemplated hereby, with full
power and authority to act on his, her or its behalf, and to act as his, her or
its true and lawful attorney-in-fact and agent for all purposes under this
Agreement and the transactions contemplated hereby.
7.4 HOLDBACK SHARES. At the Effective Time, the Principal Stockholders
and Management Stockholders shall deposit a total of 122,288 of the Monarch
Common Shares the Principal Stockholders and Management Stockholders received in
the Merger under the Escrow Agreement as a mechanism to satisfy claims for
indemnification by Monarch and the Surviving Corporation under this Article VII
(the "Holdback Shares"). Except for claims arising under Section 7.3.3, any
liability of the Principal Stockholders for indemnification for Losses under
this Article VII, subject to the limitations described in Section 7.3 hereof,
shall be satisfied solely and exclusively from Holdback Shares pursuant to a
set-off under this Section 7.4 and the Escrow Agreement. Any liability of the
Management Stockholders for indemnification for Losses under this Article VII
shall be satisfied solely and exclusively from Holdback Shares pursuant to set
off under this Section 7.4 and the Escrow Agreement. With respect to claims
arising under Section 7.3.3, Monarch Indemnified parties shall first attempt to
satisfy claims for indemnification by recovery of the Holdback Shares.
The Principal Stockholders and Management Stockholders may elect, in
the Representative's discretion, to satisfy indemnification claims under this
Article VII through the payment of cash in the full amount of the claim rather
than through set-off under this Section 7.4 and the Escrow Agreement.
7.4.1 Release of Holdback Shares. The Escrow Agent shall hold
the Holdback Shares in accordance with this Agreement and shall transfer the
Holdback Shares only as follows:
(a) Holdback Shares shall be re-transferred to
Monarch in respect of indemnification claims made by Monarch or the
Surviving Corporation under this Article VII when, and to the extent,
authorized under Section 7.4.2 below.
(b) On the Holdback Termination Date (as defined
below), any Holdback Shares then remaining pledged to Monarch (which
shall exclude shares re-transferred to Monarch under paragraph (a))
shall be released to the Principal Stockholders and the Management
Stockholders pro rata in accordance with their
43
<PAGE> 47
percentage ownership of the Company immediately prior to the Merger, as
set forth in Section 5.3.3 of the Company Disclosure Schedule.
Except as otherwise set forth in Section 7.4.4 below, for purposes of
this Agreement, the "Holdback Termination Date" shall mean the date which is
fifteen (15) months after the Closing Date, except to the extent necessary to
indemnify against Open Claims (as hereinafter defined) as contemplated by
Section 7.3.2, for which the "Holdback Termination Date" shall mean the date on
which all such matters are finally determined and disposed of.
7.4.2 Claims Procedure. The procedure for payment from the
Holdback Shares of indemnification amounts to which Monarch Indemnified Parties
may become entitled under this Article VII shall be as follows:
(a) Subject to the limitation that written notice of
any Monarch Indemnifiable Claim hereunder must be given to the
Principal Stockholders and the Management Stockholders not later than
the Holdback Termination Date, from time to time as Monarch determines
that it or another Monarch Indemnified Party is entitled to an
indemnification payment under this Article VII, Monarch shall give
written notice of the Claim to the Principal Stockholders and the
Escrow Agent in accordance with Section 7.8.
(b) If the Escrow Agent has not received written
objection to a Claim in accordance with the preceding subparagraph (a)
from the Representative within thirty (30) days after notice of such
Claim is delivered to the Representative (the "Response Period"), the
Claim stated in such notice shall be conclusively deemed to be approved
by the Principal Stockholders and the Management Stockholders, and the
Escrow Agent shall promptly thereafter transfer to the Monarch
Indemnified Party from the Holdback Shares an amount of Holdback Shares
equal in value to the amount of such Claim based on an assumed
valuation of $15.25 per share, with such Holdback Shares taken from the
Principal Stockholders and the Management Stockholders pro rata in
accordance with their percentage ownership of the Company prior to the
Merger. The Holdback Shares to be transferred shall be rounded to the
nearest whole share and shall be valued on the basis of such valuation.
(c) If within the Response Period the Escrow Agent
shall have received from the Representative, a written objection to the
claim specifying the nature of and grounds for such objection, then
such claim shall be deemed to be open ("Open Claim"), and the Escrow
Agent shall reserve within the Holdback Shares an amount of Holdback
Shares equal to the amount of such Open Claim (which amount designated
for each Open Claim is referred to herein as the "Claim Reserve
Amount"). The number of Holdback Shares to be reserved shall be
determined (rounded to the nearest whole share) by dividing the amount
of the Open Claim by a value per Holdback Share of $15.25, with such
Holdback Shares taken from the Principal Stockholders and the
Management Stockholders pro rata in accordance with their percentage
ownership of the Company
44
<PAGE> 48
prior to the Merger; provided, however that the Principal Stockholders
and Management Stockholders may deliver cash in lieu of the Holdback
Shares as provided in Section 7.4.3 below.
(d) The Claim Reserve Amount for each Open Claim
shall be transferred by the Escrow Agent from the Holdback Shares only
in accordance with either (i) a mutual agreement among Monarch and the
Representative, which shall be memorialized in writing, or (ii) a final
and binding arbitration decision or order pertaining to the Open Claim,
except that on the Holdback Termination Date all Holdback Shares not
previously distributed or then required to be distributed to Monarch in
accordance with this Section 7.4 shall be released to the Principal
Stockholders and the Management Stockholders pro rata in accordance
with their percentage ownership of the Company prior to the Merger, as
set forth in Section 5.3.3 of the Company Disclosure Schedule whether
or not all Open Claims have then been resolved.
7.4.3 Voting; Disposition. The Holdback Shares shall be held
of record by the Principal Stockholders and the Management Stockholders, who
shall have the right to vote the Holdback Shares on all matters coming before
the stockholders of Monarch. If any Principal Stockholder or Management
Stockholder transfers Holdback Shares prior to the Holdback Termination Date,
such Principal Stockholder or Management Stockholder shall promptly deposit with
the Escrow Agent an amount of cash equal to $15.25 for each Holdback Share so
transferred, and as a condition to such transfer, the Escrow Agent shall require
a written agreement from the Principal Stockholder or Management Stockholder,
reasonably satisfactory to Monarch, depositing such cash proceeds with the
Escrow Agent.
7.4.4 Merger or Recapitalization. In the event of any merger
or recapitalization or similar transaction involving Monarch prior to the time
when all Holdback Shares have been transferred or released in accordance with
the terms of this Section 7.4, such Holdback Shares shall be converted or
exchanged in accordance with such transaction in the same manner as other shares
of Monarch Common Stock, and any securities or property issued in conversion or
exchange thereof shall then be included within the definition of Holdback Shares
and shall otherwise become subject to this Agreement in lieu of such share of
Monarch Common Stock.
7.4.5 Taxation of Dividends. Each Principal Stockholder hereby
acknowledges that, for federal and state income tax purposes, any dividends or
other distributions with respect to the Holdback Shares shall be income of the
Principal Stockholders.
7.5 INDEMNIFICATION BY MONARCH. Monarch agrees, in all cases subject
to the limitations set forth in this Article VII, subsequent to the Closing Date
to indemnify and hold harmless the Principal Stockholders ("Company Indemnified
Parties") from and against and in respect of all Losses sustained, suffered or
incurred by or made against any of them arising out of or based upon (a) any
breach of any representation or warranty made by Monarch pursuant to Section 5.2
of this Agreement; and (b) any breach of any covenant made by Monarch in this
Agreement or in any Schedule hereto (such claims under clauses (a) and (b) being
hereinafter
45
<PAGE> 49
collectively referred to as "Company Indemnifiable Losses"). Indemnification
under this Section 7.5 shall be payable as set forth in Section 7.7.
7.6 LIMITATIONS ON INDEMNIFICATION BY MONARCH.
7.6.1 General Threshold; Maximum Indemnification. Subject to
the exceptions set forth in Section 7.6.3, Monarch shall not be obligated to
indemnify the Company Indemnified Parties in respect of the Company
Indemnifiable Losses except to the extent that the cumulative amount of all the
Company Indemnifiable Losses shall exceed $250,000 (the "Company Threshold"),
which excess cumulative amount shall be recoverable in accordance with the terms
hereof. Subject to the exceptions set forth in Section 7.6.3, Monarch's
aggregate liability for Company Indemnifiable Losses shall not exceed
$1,864,892.
7.6.2 Time Limit for Claims. No claim for indemnification
may be made by any Company Indemnified Party in respect of the Company
Indemnifiable Losses unless the written notice thereof (including the written
notice required by Section 7.8) shall have been received by Monarch on a date
prior to the date that is fifteen (15) months after the Closing Date; provided,
however, that if prior to the applicable date of expiration a specific state of
facts shall have become known which is reasonably likely to constitute or give
rise to any Company Indemnifiable Loss as to which indemnity may be payable and
a Company Indemnified Party shall have given notice of such facts to Monarch and
made a claim for indemnification and, except with respect to third party claims,
pursued such claim within six months thereafter, then the right to
indemnification with respect thereto shall remain in effect until such matter
shall have been finally determined and disposed of and any indemnification due
in respect thereof shall have been paid.
7.6.3 Dollar-for-Dollar Claims. Notwithstanding anything
herein to the contrary, the Company Indemnified Parties shall not be subject to
any limitation under Section 7.6.1 in seeking indemnification with respect to
any Company Indemnifiable Loss (a) involving fraud or an intentional
misrepresentation by Monarch, or (b) arising from breach of a covenant by
Monarch.
7.7 PAYMENT OF INDEMNIFICATION BY MONARCH. Any indemnification
properly payable by Monarch pursuant to this Article VII shall be either in cash
(but only to the extent such payment does not change the tax-free nature of the
Merger) or in additional Monarch Common Shares issued to the holders of the
Company Common Shares pro rata in proportion to their interests in the Company
immediately prior to the Effective Time and valued for purposes of satisfying
indemnification obligations at $15.25 per share, as determined by Monarch in its
sole discretion. In the case of a share delivery, the number of such Monarch
Common Shares to be issued will be determined by dividing (a) the amount of such
indemnification payable by Monarch by (b) $15.25 per share. Such additional
Monarch Common Shares shall be duly authorized, validly issued, fully paid and
non-assessable and shall be issued within fifteen (15)
46
<PAGE> 50
business days after the Representative's request therefor and after final,
unappealable determination of liability so provided for in this Article VII or,
with respect to any settlement, upon final settlement.
7.8 NOTICE; DEFENSE OF CLAIMS; LOSS REDUCTION . Promptly after receipt
by an indemnified party (whether a Monarch Indemnified party or a Company
Indemnified Party) of notice of any claim, liability or expense to which the
indemnification obligations hereunder would apply, the indemnified party shall
give notice thereof in writing to the indemnifying party, but the omission to so
notify the indemnifying party promptly will not relieve the indemnifying party
from any liability except to the extent that the indemnifying party shall have
been prejudiced as a result of the failure or delay in giving such notice. Such
notice shall state the information then available regarding the amount and
nature of such claim, liability or expense and shall specify the provision or
provisions of this Agreement under which the liability or obligation is
asserted. If within 20 days after receiving such notice the indemnifying party
gives written notice to the indemnified party stating that (i) it would be
liable under the provisions hereof for indemnity in the amount of such claim,
liability or expense if such claim were successful and (ii) that it disputes and
intends to defend against such claim, liability or expense at its own cost and
expense, then counsel for the defense shall be selected by the indemnifying
party (subject to the consent of the indemnified party which consent shall not
be unreasonably withheld or delayed) and the indemnified party shall not be
required to make any payment, and shall not make any settlement, with respect to
such claim, liability or expense as long as the indemnifying party is conducting
a good faith and diligent defense at its own expense; provided, however, that
the assumption of defense of any such matters by the indemnifying party shall
relate solely to the claim, liability or expense that is subject or potentially
subject to indemnification, and provided further that prior to such assumption
of defense the indemnifying party shall enter into an agreement with the
indemnified party in form and substance reasonably satisfactory to the
indemnified party pursuant to which the indemnifying party unconditionally
guarantees the payment and performance of any liability or obligation which may
arise out of or in any way relating to such claim, liability or expense or the
facts giving rise thereto and provides to the indemnified party evidence
reasonably satisfactory to the indemnified party of the indemnifying party's
ability to pay in full any amount which may be payable with respect to such
claim, liability or expense or the facts giving rise thereto. The indemnifying
party shall have the right, with the consent of the indemnified party, which
consent shall not be unreasonably withheld or delayed, to settle all
Indemnifiable matters related to claims by third parties which are susceptible
to being settled provided its obligation to indemnify the indemnifying party
therefor will be fully satisfied. The indemnifying party shall keep the
indemnified party apprised of the status of the claim, liability or expense and
any resulting suit, proceeding or enforcement action, shall furnish the
indemnified party with all documents and information that the indemnified party
shall reasonably request and shall consult with the indemnified party prior to
acting on major matters, including settlement discussions. Notwithstanding
anything herein stated to the contrary, the indemnified party shall at all times
have the right to fully participate in such defense at its own expense directly
or through counsel; provided, however, if the named parties to the action or
proceeding include both the indemnifying party and the indemnified party and
representation of both parties by the same
47
<PAGE> 51
counsel would be inappropriate under applicable standards of professional
conduct, the reasonable expense of separate counsel for the indemnified party
shall be paid by the indemnifying party provided that such counsel is selected
by the indemnified party and such counsel is reasonably acceptable to the
indemnifying party. If no such notice of intent to dispute and defend is given
by the indemnifying party, or if such defense is not being or ceases to be
conducted, the indemnified party shall, at the reasonable expense of the
indemnifying party, undertake the defense of (with counsel selected by the
indemnified party), and shall have the right to compromise or settle (exercising
reasonable business judgment), such claim, liability or expense. If such claim,
liability or expense is one that by its nature cannot be defended solely by the
indemnifying party, then the indemnified party shall make available all
information and assistance that the indemnifying party may reasonably request
and shall cooperate with the indemnifying party in such defense.
Damages payable to an indemnified party shall be reduced by (i) any Tax
Benefit (as hereinafter defined) actually received by the indemnified party on
account of such indemnification and (ii) any insurance proceeds actually
received by the indemnified party on account of such indemnification at the time
the indemnification payment occurs, it being understood that in no event shall
any indemnification payment be delayed in anticipation of the receipt of any Tax
Benefit or insurance proceeds. If the indemnified party receives a Tax Benefit
after an indemnification payment is made, the indemnified party shall pay to the
indemnifying party, the aggregate amount of such Tax Benefit at such time or
times as and to the extent that such Tax Benefit is received. If, upon audit by
the relevant tax authority, part or all of such Tax Benefit shall be disallowed,
the indemnifying party, upon written notice to that effect from the indemnified
party, shall promptly reimburse the indemnified party for the full amount so
disallowed up to the amount of the Tax Benefit credited to the indemnifying
party. For purposes hereof, "Tax Benefit" shall mean any refund of tax or
reduction in the amount of taxes which would otherwise be payable by reason of
payment of the Loss. The parties hereto shall seek full recovery under all
insurance policies covering any indemnification payment in the ordinary course
of business to the same extent as they would if such claim were not subject to
an indemnification payment hereunder. In the event that an insurance recovery is
made by the indemnified party, with respect to any indemnification payment for
which an indemnification claim has been made, the indemnified party shall pay to
the indemnifying party the amount of the insurance recovery, but not more than
the amount of such indemnification payment.
7.9 REMEDIES. The indemnification provisions of this Article VII are
the sole and exclusive remedy from and after the Effective Time of any party to
this Agreement for a breach of any representation, warranty or covenant
contained herein. Notwithstanding the preceding sentence, each of the parties
acknowledges and agrees that the other parties hereto would be damaged
irreparably in the event any of the provisions of this Agreement are not
performed in accordance with their specific terms or otherwise are breached.
Accordingly, each of the parties hereto agrees the other parties hereto shall be
entitled to an injunction to prevent breaches of the provisions of this
Agreement and to enforce specifically this Agreement and the terms and
provisions hereof (including the indemnification provisions hereof) in any court
of competent
48
<PAGE> 52
jurisdiction having jurisdiction over the parties, in addition to any other
remedy to which they may be entitled at law or in equity.
ARTICLE VIII
MISCELLANEOUS AND GENERAL
8.1 PAYMENT OF EXPENSES. If the Merger is consummated, the Surviving
Corporation shall pay all expenses of the parties incident to preparing for,
entering into and carrying out this Agreement and the consummation of the
transactions contemplated hereby, provided that the expenses and other amounts
payable as a result of the transactions contemplated by this Agreement
(including, without limitation, brokerage fees and commissions, attorneys' fees
and expenses and bonuses to employees) of the Company and its stockholders in
connection with the transactions contemplated hereby shall not exceed $375,000.
8.2 [RESERVED].
8.3 WAIVER OF CONDITIONS. The conditions to each of the parties'
obligations to consummate the Merger are for the sole benefit of such party and
may be waived by such party in whole or in part to the extent permitted by
applicable law.
8.4 COUNTERPARTS. For the convenience of the parties hereto, this
Agreement may be executed in any number of counterparts, each such counterpart
being deemed to be an original instrument, and all such counterparts shall
together constitute the same agreement.
8.5 GOVERNING LAW. This Agreement shall be governed by and construed
in accordance with the laws of Delaware, without regard to any applicable
conflicts of law principles.
8.6 NOTICES. Any notice, request, instruction or other document to
be given hereunder by any party to the other parties shall be in writing and
delivered personally or sent by registered or certified mail, postage prepaid,
or by facsimile transmission (with a confirming copy sent by a recognized
overnight courier), as follows:
if to Monarch, to
Monarch Dental Corporation
4201 Spring Valley Road
Suite 320
Dallas, TX 75244
Attention: Chief Executive Officer
Telephone: (972) 458-0923
Facsimile: (972) 458-0934
49
<PAGE> 53
with a copy to:
Goodwin, Procter & Hoar LLP
Exchange Place
Boston, MA 02109-2881
Attention: John R. LeClaire, P.C.
Telephone: (617) 570-1000
Facsimile: (617) 570-8150
if to the Principal Stockholders or the Management
Stockholders
c/o Foster Management Company
1018 West Ninth Avenue
King of Prussia, PA 19406
Telephone: (610) 992-7650
Facsimile: (610) 992-3390
with a copy to:
Haythe & Curley
237 Park Avenue
New York, NY 10017
Attention: Robert A. Ouimette, Esq.
Telephone: (212) 880-6000
Facsimile: (212) 682-0200
or to such other persons or addresses as may be designated in writing by the
party to receive such notice.
8.7 ENTIRE AGREEMENT; ASSIGNMENT. This Agreement, including the
Disclosure Schedules and Exhibits and Schedules hereto and the Confidentiality
Agreement dated as of February 28, 1998 by and among Monarch and the Company,
(i) constitutes the entire agreement among the parties with respect to the
subject matter hereof and supersedes all other prior agreements and
understandings, both written and oral, among the parties or any of them with
respect to the subject matter hereof, and (ii) shall not be assigned by
operation of law or otherwise.
8.8 PARTIES IN INTEREST. Subject to Section 8.7, this Agreement shall
be binding upon and inure solely to the benefit of each party hereto and their
respective successors and assigns. Nothing in this Agreement, express or
implied, other than the right to receive the consideration payable in the Merger
pursuant to Article IV hereof, is intended to or shall confer upon any other
person any rights, benefits or remedies of any nature whatsoever under or by
reason of this Agreement; provided, however, that the provisions of Article VII
shall inure to the
50
<PAGE> 54
benefit of and be enforceable by the Company Indemnified Parties and the Monarch
Indemnified Parties.
8.9 SEVERABILITY. If any term or other provision of this Agreement is
invalid, illegal or unenforceable, all other provisions of this Agreement shall
nevertheless remain in full force without rendering void, invalid or
unenforceable any other term or provision, provided that the economic or legal
substance of the transactions contemplated hereby is not, affected in any manner
materially adverse to any party.
8.10 SPECIFIC PERFORMANCE. The parties hereto acknowledge that
irreparable damage would result if this Agreement were not specifically
enforced, and they therefore consent that the rights and obligations of the
parties under this Agreement may be enforced by a decree of specific performance
issued by a court of competent jurisdiction. Such remedy shall, however, not be
exclusive and shall be in addition to any other remedies, including arbitration,
which any party may have under this Agreement or otherwise.
8.11 ARBITRATION. Any dispute arising out of or relating to this
Agreement or the breach, termination or validity hereof shall be finally settled
by binding arbitration conducted expeditiously in accordance with the Center for
Public Resources Rules for Nonadministered Arbitration of Business Disputes (the
"CPR Rules"). The Center for Public Resources shall appoint a neutral advisor
from its National CPR Panel. The arbitration shall be governed by the United
States Arbitration Act, 9 U.S.C. ss.ss.1-16, and judgment upon the award
rendered by the arbitrators may be entered by any court having jurisdiction
thereof. The place of arbitration shall be Dallas, Texas.
Such proceedings shall be administered by the neutral advisor in
accordance with the CPR Rules as he/she deems appropriate, however, such
proceedings shall be guided by the following agreed upon procedures:
8.11.1 mandatory exchange of all relevant documents, to be
accomplished within forty-five (45) days of the initiation of the procedure;
8.11.2 no other discovery;
8.11.3 hearings before the neutral advisor which shall consist
of a summary presentation by each side of not more than three hours; such
hearings to take place on one or two days at a maximum; and
8.11.4 decision to be rendered not more than ten (10) days
following such hearings.
8.12 CAPTIONS. The Article, Section and paragraph captions herein are
for convenience of reference only, do not constitute part of this Agreement and
shall not be deemed to limit or otherwise affect any of the provisions hereof.
51
<PAGE> 55
8.13 DIRECTOR AND OFFICER INDEMNIFICATION.
8.13.1 The parties agree that the certificate of incorporation
and the bylaws of the Surviving Corporation will contain the provisions with
respect to exculpation from liability and indemnification set forth in Exhibits
2.1 and 2.2, respectively, which provisions shall not be amended, repealed, or
otherwise modified in any manner that would adversely affect the rights
thereunder of individuals who at the Effective Time were present or former
directors, officers, employees, or agents of the Company, unless such
modification is required by law, provided, however, that the surviving
corporation shall not be required to indemnify present or former directors and
officers of the Company for matters giving rise to Monarch Indemnifiable losses.
8.13.2 If the Surviving Corporation or any of its successors
or assigns (i) shall consolidate with or merge into any other Person and shall
not be the continuing or surviving Person of such consolidation or merger or
(ii) shall transfer all or substantially all of its properties and assets to any
Person, then and in each such case, proper provisions shall be made so that the
successors and assigns of the Surviving Corporation shall assume all of the
obligations set forth in this Section 8.13.
8.13.3 The provisions of this Section 8.13 are intended to be
for the benefit of, and shall be enforceable by, each of the present and former
directors and officers of the Company, and their heirs and their
representatives.
8.14 GRANT OF OPTIONS. Immediately following the Closing Date, Monarch
shall grant to those persons listed in Section 8.15 of the Company Disclosure
Schedule options to purchase a total of 350,000 Monarch Common Shares under
Monarch's 1996 Stock Option and Grant Plan as amended (the "Monarch Plan") at a
price equal to the Fair Market Value of one Monarch Common Share, as defined in
the Monarch Plan.
[END OF TEXT]
52
<PAGE> 56
IN WITNESS WHEREOF, this Agreement has been duly executed and delivered
by the duly authorized officers of the parties hereto, except that the
Management Stockholders listed below shall be deemed to be executing only
Sections 4.4, 5.1.1, 5.1.2, 5.1.3, 7 and 8, and the Agreement shall be effective
as of the date first hereinabove written.
MONARCH DENTAL CORPORATION
By: /s/ GARY W. CAGE
-------------------------------------
Name: Gary W. Cage
-----------------------------------
Title: Chief Executive Officer
----------------------------------
VALLEY FORGE DENTAL ASSOCIATES, INC.
By: /s/ JOSEPH J. FRANK
-------------------------------------
Name: Joseph J. Frank
-----------------------------------
Title: President
----------------------------------
, INC.
--------------------------
By:
-------------------------------------
Name:
-----------------------------------
Title:
----------------------------------
PRINCIPAL STOCKHOLDERS:
----------------------------------------
BUSINESS DEVELOPMENT CAPITAL
LIMITED PARTNERSHIP-III
By: BDC-III Partners, its general partner
By: /s/ STEPHEN F. NAGY
-------------------------------------
53
<PAGE> 57
ABBINGDON VENTURE PARTNERS
LIMITED PARTNERSHIP
By: BDC-III Partners, its general partner
By: /s/ STEPHEN F. NAGY
--------------------------------------------------
ABBINGDON VENTURE PARTNERS
LIMITED PARTNERSHIP-II
By: Abbingdon-II Partners, its general partner
By: /s/ STEPHEN F. NAGY
--------------------------------------------------
ABBINGDON VENTURE PARTNERS
LIMITED PARTNERSHIP-III
By: Abbingdon-II Partners, its general partner
By: /s/ STEPHEN F. NAGY
--------------------------------------------------
54
<PAGE> 58
MANAGEMENT STOCKHOLDERS:
/s/ STATHIS ANDRIS
--------------------------------
Stathis Andris
/s/ COLIN C. BLAYDON
--------------------------------
Colin C. Blaydon
/s/ JOSEPH J. FRANK
--------------------------------
Joseph J. Frank
/s/ W. GARY LIDDICK
--------------------------------
W. Gary Liddick
/s/ ROBERT K. MEHLMAN
--------------------------------
Robert K. Mehlman
/s/ STEPHEN E. O'NEIL
--------------------------------
Stephen E. O'Neil
/s/ JEANNE MARIE WELSKO
--------------------------------
Jeanne Marie Welsko
55
<PAGE> 59
CERTIFICATIONS
It is hereby certified that the holders of a majority of the
outstanding shares of each class of Valley Forge Dental Associates, Inc.
entitled to vote on this Agreement and Plan of Merger have approved adoption of
such Agreement by means of a written consent dated September 9, 1998, as
permitted by Section 228 of the Delaware General Corporation Law.
/s/ W. GARY LIDDICK
-----------------------------------------
Secretary
Valley Forge Dental Associates, Inc.
It is hereby certified that all of the outstanding shares of each class
of DFV Acquisition Corp. entitled to vote on this Agreement and Plan of Merger
have voted approved adoption of Agreement by means of a written consent dated
September 9, 1998, as permitted by Section 228 of the Delaware General
Corporation Law.
/s/ STEVEN G. PETERSON
-----------------------------------------
Steven G. Peterson
Secretary
DFV Acquisition Corp.
56
<PAGE> 60
Schedule 5.3.3
(Capitalization including total authorized capital stock and the number of
shares of capital stock and options, convertible securities and warrants issued
and outstanding)
The Company's capital stock is as follows:
Preferred Stock:
1,000,000 shares of 8% Cumulative Preferred Stock authorized, of which 8,000
shares were outstanding as of August 31, 1998.*
<TABLE>
<CAPTION>
Date of Certificate Number of Shareholder
Issuance Number(s) Shares
==============================================================================================
<S> <C> <C> <C>
8/11/95 1 400 Business Development Capital
Limited Partnership-III
- ----------------------------------------------------------------------------------------------
8/11/95 2 1,080 Abbingdon Venture Partners Limited
Partnership
- ----------------------------------------------------------------------------------------------
8/11/95 3 3,960 Abbingdon Venture Partners Limited
Partnership-II
- ----------------------------------------------------------------------------------------------
8/11/95 4 2,560 Abbingdon Ventures Partners
Limited Partnership-III
- ----------------------------------------------------------------------------------------------
</TABLE>
*Will be cancelled as of the Effective Time.
Common Stock:
20,000,000 shares authorized, 4,755,286 outstanding.
<TABLE>
<CAPTION>
Date of Certificate Number of Shareholder
Issuance Number(s) Shares
==============================================================================================
<S> <C> <C> <C>
8/11/95 1 175,000 Business Development Capital
Limited Partnership - III
- ----------------------------------------------------------------------------------------------
8/11/95 2 472,500 Abbingdon Venture Partners Limited
Partnership
- ----------------------------------------------------------------------------------------------
8/11/95 3 1,732,500 Abbingdon Venture Partners Limited
Partnership-II
- ----------------------------------------------------------------------------------------------
8/11/95 4 1,120,000 Abbingdon Venture Partners Limited
Partnership-III
- ----------------------------------------------------------------------------------------------
9/15/95 5 50,000 Bruce L. Talus
- ----------------------------------------------------------------------------------------------
9/15/95 6 50,000 Robert K. Mehlman
- ----------------------------------------------------------------------------------------------
12/31/95 7 2,500 W. Gary Liddick
12/17/96 9 5,000
- ----------------------------------------------------------------------------------------------
</TABLE>
<PAGE> 61
Schedule 5.3.3 (continued)
<TABLE>
<CAPTION>
Date of Certificate Number of Shareholder
Issuance Number(s) Shares
==============================================================================================
<S> <C> <C> <C>
1/31/96 8 12,500 Donald L. Kane, D.D.S., P.A.
5/14/97 30 5,887
6/25/98 83 2,892
- ----------------------------------------------------------------------------------------------
11/25/96 10 5,000 Stathis Andris
- ----------------------------------------------------------------------------------------------
11/25/96 11 5,000 Stephen E. O'Neil
- ----------------------------------------------------------------------------------------------
12/17/96 12 7,500 Jeanne Welsko
- ----------------------------------------------------------------------------------------------
12/17/96 13 150,000 Joseph J. Frank
- ----------------------------------------------------------------------------------------------
1/15/97 14 5,000 Allan M. Dworkin, D.D.S.
10/23/97 63 15,000
- ----------------------------------------------------------------------------------------------
1/29/97 17 1,248 Western Dental Group of Fort
6/l/98 82 3,770 Collins, P.C.
- ----------------------------------------------------------------------------------------------
1/29/97 18 455 Western Dental Group of Cascade
6/l/98 79 1,375 Avenue, P.C.
- ----------------------------------------------------------------------------------------------
1/29/97 19 1,668 Western Dental Group of Academy
6/l/98 80 5,040 Boulevard, P.C.
- ----------------------------------------------------------------------------------------------
1/29/97 20 1,317 Western Dental Group of Denver,
6/l/98 81 3,981 P.C.
- ----------------------------------------------------------------------------------------------
2/19/97 22 25,000 Eugene N. Witkin, D.D.S.
- ----------------------------------------------------------------------------------------------
2/19/97 23 37,500 ENW, Inc.
- ----------------------------------------------------------------------------------------------
4/18/97 24 42,727 Lawrence P. Rudolph, D.M.D.
7/28/98 89 7,121
- ----------------------------------------------------------------------------------------------
4/18/97 25 42,727 John E. Tiano, D.D.S.
7/28/98 88 7,121
- ----------------------------------------------------------------------------------------------
4/18/97 26 5,455 Timothy J. Runco, D.M.D.
7/28/98 90 909
- ----------------------------------------------------------------------------------------------
27 4,384 Richard W. Aros, D.D.S.
6/11/97 34 6,250
6/l/98 77 6,250
- ----------------------------------------------------------------------------------------------
28 4,384 Roberta Aros
6/11/97 35 6,250
6/l/98 78 6,250
- ----------------------------------------------------------------------------------------------
</TABLE>
<PAGE> 62
Schedule 5.3.3 (continued)
<TABLE>
<CAPTION>
Date of Certificate Number of Shareholder
Issuance Number(s) Shares
==============================================================================================
<S> <C> <C> <C>
5/21/97 32 3,067 Meyer & Lloyd, P.C., Frederick W.
Meyer, Jr., D.D.S., and Harvey C.
Lloyd, D.D.S.
- ----------------------------------------------------------------------------------------------
5/21/97 33 25,000 Kenneth Tralongo, D.D.S.
- ----------------------------------------------------------------------------------------------
7/2/97 36 3,667 Maurice E. Smith, D.D.S.
- ----------------------------------------------------------------------------------------------
7/28/97 38 3,333 Bernard B. Baros, D.D.S.
- ----------------------------------------------------------------------------------------------
8/15/97 40 15,000 Douglass A. Quinn, D.D.S.
- ----------------------------------------------------------------------------------------------
9/8/97 41 2,667 Delbert B. Williamson, D.D.S.
- ----------------------------------------------------------------------------------------------
9/22/97 42 13,333 Kenneth E. Copeland, D.D.S.
- ----------------------------------------------------------------------------------------------
9/17/97 43 10,833 David Wells, D.D.S.
- ----------------------------------------------------------------------------------------------
9/30/97 44 2,917 Felix W. Sibley, D.D.S.
- ----------------------------------------------------------------------------------------------
9/30/97 45 2,667 Larry J. Miller, D.M.D.
- ----------------------------------------------------------------------------------------------
9/30/97 46 2,667 James H. Powell, D.M.D.
- ----------------------------------------------------------------------------------------------
10/1/97 47 31,259 Mark Perecman
- ----------------------------------------------------------------------------------------------
10/1/97 48 20,843 George Frattali
- ----------------------------------------------------------------------------------------------
10/1/97 49 22,966 Gary Mink
- ----------------------------------------------------------------------------------------------
10/1/97 50 12,319 Norman Kurtzman
- ----------------------------------------------------------------------------------------------
10/1/97 51 10,792 Kevin O'Meara
- ----------------------------------------------------------------------------------------------
10/1/97 52 9,829 Jeffrey Leiss
- ----------------------------------------------------------------------------------------------
10/1/97 53 9,202 James Dyen
- ----------------------------------------------------------------------------------------------
10/1/97 54 9,075 Michael Pavel
- ----------------------------------------------------------------------------------------------
10/1/97 56 7,612 Richard Valenci
- ----------------------------------------------------------------------------------------------
9/30/97 57 4,200 Kenneth Bradley Reynolds
- ----------------------------------------------------------------------------------------------
9/30/97 58 1,333 Charles L. Smith
- ----------------------------------------------------------------------------------------------
10/1/97 59 1,272 Eleanore Meredith
- ----------------------------------------------------------------------------------------------
10/1/97 60 7,033 Mark Carleton
- ----------------------------------------------------------------------------------------------
10/1/97 61 7,122 Edward Balling
- ----------------------------------------------------------------------------------------------
10/23/97 62 8,426 Cemil Yesilsoy
- ----------------------------------------------------------------------------------------------
</TABLE>
<PAGE> 63
Schedule 5.3.3 (continued)
<TABLE>
<CAPTION>
Date of Certificate Number of Shareholder
Issuance Number(s) Shares
==============================================================================================
<S> <C> <C> <C>
10/23/97 64 3,750 Douglas K. Clemens, D.M.D.
- ----------------------------------------------------------------------------------------------
10/22/97 66 12,500 James A. Russo
- ----------------------------------------------------------------------------------------------
10/22/97 67 12,500 Robert Perri
- ----------------------------------------------------------------------------------------------
10/22/97 68 133,500 Richard Poller, D.D.S.
10/22/97 70 41,667
8/5/98 94 10,416
- ----------------------------------------------------------------------------------------------
10/22/97 69 133,500 Craig Abramowitz, D.D.S.
10/22/97 71 41,666
8/5/98 93 10,417
- ----------------------------------------------------------------------------------------------
10/22/97 72 37,500 Union Marketing Associates, Inc.
- ----------------------------------------------------------------------------------------------
11/25/96 73 5,000 Colin C. Blaydon
- ----------------------------------------------------------------------------------------------
4/14/98 74 10,000 Ramon A. Woodall III, D.D.S.
- ----------------------------------------------------------------------------------------------
4/20/98 75 8,000 Charles Mazza, D.D.S.
- ----------------------------------------------------------------------------------------------
4/20/98 76 8,000 Michael Matkov, D.D.S.
- ----------------------------------------------------------------------------------------------
6/25/98 84 975 UDG, Melbourne, P.A.
- ----------------------------------------------------------------------------------------------
Total 4,755,286
- ----------------------------------------------------------------------------------------------
</TABLE>
As of August 31, 1998 the aggregate number of shares of common stock issued and
outstanding is 4,755,286.
All of the issued and outstanding shares of Common Stock and Preferred Stock
have each been duly authorized, are validly issued, fully paid, and
nonassessable.
<PAGE> 1
Exhibit 2.2
REGISTRATION RIGHTS AGREEMENT
THIS AGREEMENT is dated as of the 1st day of September, 1998, by and
among Monarch Dental Corporation, a Delaware corporation (the "Company"), and
the persons listed on Exhibit A hereto (each, a "Holder" and collectively, the
"Holders").
WHEREAS, each Holder has heretofore been a stockholder of Valley Forge
Dental Associates, Inc. ("Valley Forge");
WHEREAS, each Holder has received shares of Common Stock of the Company
in a private placement in connection with a merger of a subsidiary of the
Company with and into Valley Forge;
NOW, THEREFORE, for good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the Company and the Holders hereby
covenant and agree with each other as follows:
1. CERTAIN DEFINITIONS. As used in this Agreement, the following terms
shall have the following respective meanings:
"BOARD OF DIRECTORS" means the Board of Directors of the Company.
"COMMISSION" shall mean the United States Securities and Exchange
Commission, or any other federal agency at the time administering the Securities
Act and the Exchange Act.
"COMMON STOCK" shall mean Common Stock, par value $.01 per share, of
the Company, and any other securities into which or for which any of the
securities described above may be converted or exchanged pursuant to a plan of
recapitalization, reorganization, merger, sale of assets or otherwise.
"COMPANY" shall refer to the Company and any successor or successors
thereto.
"EXCHANGE ACT" shall mean the Securities Exchange Act of 1934, as
amended, or any similar successor federal statute, and the rules and regulations
of the Commission thereunder, all as the same shall be in effect at the time.
<PAGE> 2
"PERSON" shall mean an individual, a corporation, a partnership, a
joint venture, a trust, an unincorporated organization, a limited liability
company or partnership, a government and any agency or political subdivision
thereof.
"REGISTRABLE SECURITIES" shall mean (i) any shares of Common Stock
held by a Holder and (ii) any other securities issued and issuable with respect
to any such shares described in clause (i) above by way of a stock dividend or
stock split or in connection with a combination of shares, recapitalization,
merger, consolidation or other reorganization; provided, however, that
notwithstanding anything to the contrary contained herein, "Registrable
Securities" shall not at any time include any securities (a) registered pursuant
to the Securities Act, (b) sold to the public pursuant to Rule 144 promulgated
under the Securities Act or pursuant to an effective registration statement
under the Securities Act or (c) which could then be sold in accordance with Rule
144 under the Securities Act (including in accordance with the limitations
described in subsection (e) of Rule 144), measured as of the date of the notice
delivered to the Holders by the Company under Section 2.
"SECURITIES ACT" shall mean the Securities Act of 1933, as amended,
or any similar successor federal statute, and the rules and regulations of the
Commission thereunder, all as the same shall be in effect at the time.
2. PIGGYBACK REGISTRATION. If the Company at any time proposes to
register any of its Common Stock under the Securities Act for sale to the public
except with respect to registration statements on Forms S-4, S-8 or another form
not available for registering the Registrable Securities for sale to the
public), each such time it will give written notice as contemplated by Section
8(a) at the applicable address of record to each Holder of Registrable
Securities as indicated on Exhibit A hereto, or such other address of which any
Holder shall notify the Company in writing, of its intention to do so. Upon the
written request of any Holders of the Registrable Securities received by the
Company within twenty (20) days after receipt by such Person of such notice, the
Company will, subject to the limits contained in this Section 2, use
commercially reasonable efforts to cause such number of Registrable Securities
of said requesting Holders to be registered under the Securities Act and
qualified for sale under any state blue sky law in connection with such
registration for the period such registration remains effective, such period to
be determined by the Company in its sole discretion; provided, however, that if
the Company is advised in writing in good faith by any managing underwriter of
the Company's securities being offered in a public offering pursuant to such
registration statement, or if the Company's Board of Directors otherwise
determines in good faith based on the written advice of an investment banker,
that the amount to be sold by persons other than the Company (collectively,
"Selling Stockholders") is greater than the amount which can be offered without
adversely affecting the offering or the trading market for the Company's Common
Stock, the Company may reduce the amount offered for the accounts of Selling
Stockholders (including Holders of shares of Registrable Securities) to a number
deemed satisfactory by such managing underwriter or the Board. If any limitation
of the number of shares of Registrable
2
<PAGE> 3
Securities to be registered by the Holders is required pursuant to this Section
2, the number of shares that may be included in the registration on behalf of
the Holders shall be allocated among the Holders and the holders of any other
contractual incidental registration rights (including, without limitation, the
rights of the holders of registration rights under that certain Amended and
Restated Stockholders' Agreement (the "Stockholders' Agreement") dated as of
August 29, 1996, by and among the Company and the Investors (as defined
therein)), in proportion, as nearly as practicable, to their respective holdings
of Registrable Securities and other securities for which the holders have
contractual registration rights; provided, however, that participating Holders
within any Investor Group (as defined in the Stockholders' Agreement and
including for purposes of this Agreement, the Holders of a separate Investor
Group) shall have the first right to include shares in place of
non-participating Holders within such Investor Group before shares are allocated
to participating Holders within any other Investor Group.
In connection with any registration which is an underwritten public
offering, the right of any Person to participate in such registration shall be
conditioned upon their participation in such underwritten public offering, the
execution of any underwriting custody and power of attorney agreements
reasonably requested by the managing underwriter or the Company and the
inclusion of their Registrable Securities in such underwritten public offering
to the extent provided herein.
3. REGISTRATION PROCEDURES.
(a) If and whenever the Company undertakes pursuant to Section 2 of
this Agreement to use its commercially reasonable efforts to effect the
registration of any of its securities under the Securities Act, the Company
will:
(i) furnish to each selling Holder, such reasonable number of
copies of such registration statement, any amendments thereto, any documents
incorporated by reference therein, the prospectus, including a preliminary
prospectus, in conformity with the requirements of the Securities Act, and such
other documents as such selling Holder may reasonably request in order to
facilitate the public sale or other disposition of the securities owned by such
selling Holder;
(ii) promptly notify each selling Holder of Registrable
Securities of the happening of any event which makes any statement made in the
registration statement or related prospectus untrue or which requires the making
of any changes in such registration statement or prospectus so that they will
not contain any untrue statement of a material fact or omit to state any
material fact required to be stated therein or necessary to make the statements
therein in the light of the circumstances under which they were made not
misleading, provided that each Holder agrees that, upon receipt of notice from
the Company of the happening of any event of the kind described herein, such
Holder will forthwith discontinue disposition of Registrable Securities pursuant
to such registration statement until such Holder's receipt of the copies of the
3
<PAGE> 4
supplemented or amended prospectus (which the Company shall furnish promptly to
such Holder), and, if so directed by the Company, such Holder will deliver to
the Company all copies then in its possession of the prospectus covering such
Registrable Securities at the time of receipt of such notice; and
(iii) make generally available to its security holders, in each
case as soon as practicable, but not later than 45 days after the close of the
period covered thereby, an earnings statement of the Company which will satisfy
the provisions of Section 11(a) of the Securities Act and Rule 158 thereunder
(or any comparable successor provisions).
(b) Each Holder agrees in connection with each registration
hereunder to provide all information reasonably requested by the Company and
take such reasonable action as the Company may reasonably request to facilitate
such registration. Each holder further agrees, if requested by the Company and
an underwriter of Registrable Securities of the Company in connection with any
underwritten public offering of the Company, not to sell or otherwise transfer
or dispose of any shares held by it for such period, not to exceed one hundred
eighty (180) days following the effective date of the relevant registration
statement filed under the Securities Act, as such underwriter shall specify
reasonably and in good faith, which period shall not be longer than the lock-up
period agreed to by the directors and executive officers of the Company in
connection with such offering.
4. EXPENSES. The Company will pay the registration and filing fees,
printing expenses and fees and disbursements of counsel and accountants of the
Company and expenses of complying with the securities or blue sky laws of any
jurisdictions in connection with requests by Holders for registration hereunder.
All underwriting fees, commissions or discounts and expenses of any counsel to
the Holders shall be paid by the Holders.
5. INDEMNIFICATION.
(a) The Company shall indemnify and hold harmless the selling
Holder of Registrable Securities and each other Person, if any, who controls
(within the meaning of the Securities Act) such seller (individually and
collectively, the "Indemnified Person") against any losses, claims, damages,
liabilities or expenses (collectively, the "liability") to which such
Indemnified Person may become subject under the Securities Act or any other
statute or at common law, insofar as such liability (or action in respect
thereof) arises out of or is based upon (i) any untrue statement or alleged
untrue statement of any material fact contained, on the effective date thereof,
in any registration statement under which such securities were registered under
the Securities Act, any preliminary prospectus or final prospectus contained
therein, or any amendment or supplement thereto, or (ii) any omission or alleged
omission to state therein a material fact required to be stated therein or
necessary to make the statements therein not misleading; provided, however, that
the Company shall not be liable to any Indemnified Person in any such case to
the extent that any such liability arises out of or is based upon any untrue
4
<PAGE> 5
statement or alleged untrue statement or omission or alleged omission made in
such registration statement, preliminary or final prospectus, or amendment or
supplement thereto in reliance upon and in conformity with information furnished
in writing to the Company by such Person specifically for use therein; and
provided further, that the Company shall not be required to indemnify any Person
against any liability arising from any untrue or misleading statement or
omission contained in any preliminary prospectus if such deficiency is corrected
in the final prospectus (provided the Company has complied with its obligations
in Section 3(a)(i)) or for any liability which arises out of the failure of any
Person to deliver a prospectus as required by the Securities Act.
(b) Each selling Holder of any securities included in such
registration being effected shall indemnify and hold harmless each other selling
Holder of any securities, the Company, its directors and officers, each
underwriter and each other Person, if any, who controls the Company or such
underwriter (individually and collectively also the "Indemnified Person"),
against any liability (as defined in Section 5(a)), joint or several, to which
any such Indemnified Person may become subject under the Securities Act or any
other statute or at common law, insofar as such liability (or actions in respect
thereof) arises out of or is based upon (i) any untrue statement or alleged
untrue statement of any material fact contained, on the effective date thereof,
in any registration statement under which securities were registered under the
Securities Act at the request of such selling Holder, any preliminary prospectus
or final prospectus contained therein, or any amendment or supplement thereto,
or (ii) any omission or alleged omission by such selling Holder to state therein
a material fact required to be stated therein or necessary to make the
statements therein not misleading, in the case of (i) and (ii) to the extent,
but only to the extent, that such untrue statement or alleged untrue statement
or omission or alleged omission was made in such registration statement,
preliminary or final prospectus, amendment or supplement thereto in reliance
upon and in conformity with information furnished in writing to the Company by
such selling Holder specifically for use therein; provided, however, that the
liability of a selling Holder for indemnification under this Section 5(b) shall
not exceed the proceeds received by such selling Holder from its sale of
securities under such registration statement.
(c) If the indemnification provided for in this Section 5 for any
reason is held by a court of competent jurisdiction to be unavailable to an
indemnified party in respect of any losses, claims, damages, expenses or
liabilities referred to therein, then each indemnifying party under this Section
5, in lieu of indemnifying such indemnified party thereunder, shall contribute
to the amount paid or payable by such indemnified party as a result of such
losses, claims, damages, expenses or liabilities (i) in such proportion as is
appropriate to reflect the relative benefits received by the Company, the
selling Holders and the underwriters from the offering of the Registrable
Securities or (ii) if the allocation provided by clause (i) above is not
permitted by applicable law, in such proportion as is appropriate to reflect not
only the relative benefits referred to in clause (i) above but also the relative
fault of the Company, the other selling Holders and the underwriters in
connection with the statements or omissions which resulted in
5
<PAGE> 6
such losses, claims, damages, expenses or liabilities, as well as any other
relevant equitable considerations. The relative benefits received by the
Company, the selling Holders and the underwriters shall be deemed to be in the
same respective proportions that the net proceeds from the offering (before
deducting expenses) received by the Company and the selling Holders and the
underwriting discount received by the underwriters, in each case as set forth in
the table on the cover page of the applicable prospectus, bear to the aggregate
public offering price of the Registrable Securities. The relative fault of the
Company, the selling Holders and the underwriters shall be determined by
reference to, among other things, whether the untrue or alleged untrue statement
of a material fact or the omission or alleged omission to state a material fact
relates to information supplied by the Company, the selling Holders or the
underwriters and the parties' relative intent, knowledge, access to information
and opportunity to correct or prevent such statement or omission.
The Company, the selling Holders, and the underwriters agree that
it would not be just and equitable if contribution pursuant to this Section 5
were determined by pro rata or per capita allocation or by any other method of
allocation which does not take account of the equitable considerations referred
to in the immediately preceding paragraph. In no event, however, shall a selling
Holder be required to contribute any amount under this Section 5(c) in excess of
the lesser of (i) that proportion of the total of such losses, claims, damages
or liabilities indemnified against equal to the proportion of the total
Registrable Securities sold under such registration statement which are being
sold by such selling Holder or (ii) the proceeds received by such selling Holder
from its sale of Registrable Securities under such registration statement. No
person found guilty of fraudulent misrepresentation (within the meaning of
Section 11(f) of the Securities Act) shall be entitled to contribution from any
person who was not found guilty of such fraudulent misrepresentation.
(d) In the event the Company, any selling Holder or other Person
receives a complaint, claim or other notice of any liability or action, giving
rise to a claim for indemnification under Sections 5(a) or (b) above, the Person
claiming indemnification under such paragraphs shall promptly notify the Person
against whom indemnification is sought of such complaint, notice, claim or
action, and such indemnifying Person shall have the right to investigate and
defend any such loss, claim, damage, liability or action. The Person claiming
indemnification shall have the right to employ separate counsel in any such
action and to participate in the defense thereof but the fees and expenses of
such counsel shall not be at the expense of the Person against whom
indemnification is sought (unless the indemnifying party fails to promptly
defend or unless in the reasonable opinion of counsel for the Person claiming
indemnification, a conflict exists, in which case the reasonable fees and
expenses of such separate counsel shall be borne by the Person against whom
indemnification is sought (except that the Company shall only be obligated to
bear the reasonable fees and expenses of one such separate counsel for all
Holders including shares in any Registration Statement)). In no event shall a
Person against whom indemnification is sought be obligated to indemnify any
Person for
6
<PAGE> 7
any settlement of any claim or action effected without the indemnifying Person's
prior written consent.
6. AMENDMENTS. The provisions of this Agreement may be amended, and
the Company may take any action herein prohibited or omit to perform any act
herein required to be performed by it, only with the written consent of the
Company and a majority in interest (based on then current holdings of
Registrable Securities) of the Holders.
7. ASSIGNMENT. The registration rights set forth in this Agreement are
not assignable by the Holders other than pursuant to the laws of descent and
distribution provided that a permitted assignee of such registration rights must
consent in writing to be bound by the terms and conditions of this Agreement in
order to acquire the rights granted pursuant to this Agreement; provided,
however, that each Principal Stockholder (as defined in the Agreement and Plan
of Merger dated as of September 1, 1998 by and among the Company, Valley Forge
and certain other parties thereto) may assign its registration rights and
related obligations with respect to Registrable Securities to such Principal
Stockholder's partners (it being understood that no further assignment shall be
permitted) in connection with a distribution of such Registrable Securities to
such partners if the distribution is accomplished in accordance with the
Securities Act, and if requested by the Company, the transferring Principal
Stockholder provides the Company with a legal opinion reasonably satisfactory to
the Company to that effect. In connection with any such assignment of
registration rights and related obligations, the Principal Stockholders hereby
agree that: (i) the Company shall be entitled to rely solely and conclusively
upon elections, notices, waivers and other instructions given by Foster
Management Company, Inc. ("Foster") with regard to such Registrable Securities
without reference to any instructions given by such a distributee; (ii) the
Company shall be obligated to provide notices with regard to such Registrable
Securities only to Foster and shall not be required to provide notice in any
circumstance to such distributees; (iii) the Principal Stockholders will
indemnify and hold harmless the Company from any claim, loss, liability or
damage asserted by such a distributee with regard to this Agreement and the
registration rights and related obligations created hereby; and (iv) prior to
such assignment, the Principal Stockholders will cause Foster to obtain a power
of attorney and agreement from each distributee (x) granting the power to act
for the distributee in accordance with the preceding clauses to Foster, and (y)
agreeing to the terms of this Section 7.
Upon any such transfer accomplished in accordance with this Section 7,
such transferee shall be deemed to be included within the definition of a
"Holder" for purposes of this Agreement with the rights and obligations set
forth herein, and any such Holder to which registration rights are assigned in
accordance with the prior paragraph accepts and agrees to such provisions. The
relevant Holder as the case may be, shall notify the Company at the time of such
transfer.
7
<PAGE> 8
8. MISCELLANEOUS.
(a) All notices, requests, demands and other communications
provided for hereunder shall be in writing and mailed (by first class registered
or certified mail, postage prepaid), telegraphed, sent by express overnight
courier service or electronic facsimile transmission (with a copy by mail), or
delivered to the applicable party at the addresses indicated below:
If to the Company:
Monarch Dental Corporation
4201 Spring Valley Road, Suite 320
Dallas, TX 75244
Attention: Chief Executive Officer
Telecopy No.: (972) 458-0934
With a copy to:
Goodwin, Procter & Hoar LLP
Exchange Place
Boston, MA 02109
Attention: John R. LeClaire, P.C.
Telecopy No: (617) 570-8150
If to a Holder:
At such Person's address for notice as set forth on Exhibit A
hereto or the letter of transmittal submitted by such Holder.
or, as to each of the foregoing, at such other address as shall be designated by
such Person in a written notice to the other parties (except that a Holder shall
not be required to give notice of a change of address to the other Holders)
complying as to delivery with the terms of this subsection (a). All such
notices, requests, demands and other communications shall, when mailed,
telegraphed or sent, respectively, be effective (i) two days after being
deposited in the mails or (ii) one day after being delivered to the telegraph
company, deposited with the express overnight courier service or sent by
electronic facsimile transmission, respectively, addressed as aforesaid.
(b) This Agreement shall be governed by and construed in accordance
with the laws of the State of Delaware, without giving effect to conflict of
laws principles thereof.
8
<PAGE> 9
(c) This Agreement may be executed in two or more counterparts,
each of which shall be deemed an original, but all of which together shall
constitute one and the same instrument.
(d) If any provision of this Agreement shall be held to be illegal,
invalid or unenforceable, such illegality, invalidity or unenforceability shall
attach only to such provision and shall not in any manner affect or render
illegal, invalid or unenforceable any other provision of this Agreement, and
this Agreement shall be carried out as if any such illegal, invalid or
unenforceable provision were not contained herein.
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]
9
<PAGE> 10
IN WITNESS WHEREOF, the parties hereto have caused this Registration
Rights Agreement to be duly executed as of the date first set forth above.
THE COMPANY:
MONARCH DENTAL CORPORATION
By:/s/ GARY W. CAGE
----------------------------
Name: Gary W. Cage
Title: Chief Executive Officer
BUSINESS DEVELOPMENT CAPITAL LIMITED
PARTNERSHIP-III
By: BDC-III Partners, its general partner
By: /s/ STEPHEN F. NAGY
----------------------------
ABBINGDON VENTURE PARTNERS LIMITED
PARTNERSHIP
By: BDC-III Partners, its general partner
By: /s/ STEPHEN F. NAGY
-----------------------------
ABBINGDON VENTURE PARTNERS LIMITED
PARTNERSHIP-II
By: Abbingdon-II Partners, its general partner
By: /s/ STEPHEN F. NAGY
------------------------------
<PAGE> 11
ABBINGDON VENTURE PARTNERS LIMITED
PARTNERSHIP-III
By: Abbingdon-II Partners, its general partner
By: /s/ STEPHEN F. NAGY
--------------------------------
MANAGEMENT STOCKHOLDERS:
/s/ STATHIS ANDRIS
-----------------------------------
Stathis Andris
/s/ COLIN C. BLAYDON
-----------------------------------
Colin C. Blaydon
/s/ JOSEPH J. FRANK
-----------------------------------
Joseph J. Frank
/s/ W. GARY LIDDICK
-----------------------------------
W. Gary Liddick
/s/ ROBERT K. MEHLMAN
-----------------------------------
Robert K. Mehlman
/s/ STEPHEN E. O'NEIL
-----------------------------------
Stephen E. O'Neil
/s/ JEANNE MARIE WELSKO
-----------------------------------
Jeanne Marie Welsko
<PAGE> 1
EXHIBIT 2.3
EMPLOYMENT AGREEMENT
This EMPLOYMENT AGREEMENT (the "Agreement") is made as of September
11, 1998 (the "Effective Date"), by and between Monarch Dental Corporation, a
Delaware corporation (the "Company") and Joseph J. Frank (the "Executive").
WHEREAS, reference is made to that certain Agreement and Plan of
Merger dated as of September 1, 1998, pursuant to which MDDS, Inc., a wholly
owned subsidiary of the Company, will merge with and into Valley Forge Dental
Associates, Inc. ("Valley Forge");
WHEREAS, the Executive and Valley Forge wish to terminate the
Executive's current contract for employment dated May 28, 1996 and provide that
such contract be of no further force or effect;
WHEREAS, the Executive and the Company are concurrently entering into
a Non-Competition Agreement (the "Non-Competition Agreement") with respect to
certain matters during and after the Executive's employment with the Company;
and
WHEREAS, the parties hereto desire to assure that the Executive's
knowledge and experience will be available to the Company for the period of
time set forth herein.
NOW, THEREFORE, in consideration of the mutual promises and covenants
contained herein, the parties hereto agree as follows:
1. Employment. The Company agrees to employ the Executive and the
Executive agrees to be employed by the Company on the terms and conditions set
forth in this Agreement.
2. Capacity. During the Term (as defined below), the Executive (a)
shall serve as an employee of the Company with the title and position of Chief
Operating Officer, reporting to the Chief Executive Officer of the Company (the
"CEO"), (b) shall have general supervisory responsibility in such capacity for
the dental operations of the Company, as well as such other responsibilities as
may be specified from time to time by the Board of Directors of the Company,
consistent with the Executive's position and general area of experience and
skills, provided that, in all cases the Executive shall be subject to the
oversight and supervision of the CEO of the Company in the performance of his
duties, (c) upon the request of the CEO of the Company, shall serve as an
officer and/or director of any of the Company's subsidiaries, and (d) shall
render all services reasonably incident to the foregoing. The Executive hereby
accepts such employment, agrees to serve the Company in the capacities
indicated, and agrees to use his best efforts in, and shall devote his full
working time, attention, skill and energies to, the advancement of the
interests of the Company and its subsidiaries and the performance of his duties
and responsibilities hereunder.
3. Term. Subject to the provisions of Section 5 hereof, the term of
employment pursuant to this Agreement (the "Term") shall be four (4) years from
the Effective Date.
<PAGE> 2
4. Compensation and Benefits. The regular compensation and benefits
payable to the Executive under this Agreement shall be as follows:
(a) Salary. For all services rendered by the Executive under this
Agreement, the Company shall pay the Executive a salary (the "Salary") at the
annual rate of One Hundred and Seventy-Five Thousand Dollars ($175,000), subject
to increase from time to time in the discretion of the Compensation Committee of
the Board of Directors (the "Compensation Committee"). The Salary shall be
payable in periodic installments in accordance with the Company's usual
practice for its senior executives.
(b) Bonus. In addition to the Salary payable to the Executive
pursuant to Section 4(a), during the Term, the Executive shall be eligible to
receive a bonus of up to 30% of his annual Salary based upon achievement (i) by
the Company of certain corporate and financial goals (the "Corporate Goals") and
(ii) by the Executive of certain management goals (the "Management Goals"). The
Corporate Goals and Management Goals will be set in the sole discretion of the
Board of Directors of the Company acting in good faith. Nothing in this Section
4(b) shall be deemed to create any right of the Executive to receive any bonus,
such decision on the amount of a bonus, if any, to be made in the sole and
absolute discretion of the Board of Directors of the Company or a duly appointed
committee thereof.
(c) Stock Options. Contemporaneous with the execution and delivery
of this Agreement, the Company has granted to the Executive options to acquire
50,000 shares of the Company's common stock in accordance with and subject to
option agreements dated as of even date herewith.
(d) Regular Benefits. During the Term, the Executive shall be
entitled to participate in any employee benefit plans, medical insurance plans,
life insurance plans, disability income plans, retirement plans and
arrangements, vacation plans, expense reimbursement plans and other benefit
plans which the Company may determine from time to time in its sole discretion
to have in effect for all or most of its senior executives. Such participation
shall be subject to the terms of the applicable plan documents, generally
applicable policies of the Company, applicable law and the discretion of the
Board of Directors or any administrative or other committee provided for in or
contemplated by any such plan.
(e) Taxation of Payments and Benefits. The Company shall undertake
to make deductions, withholdings and tax reports with respect to payments and
benefits under this Agreement to the extent that it reasonably and in good faith
believes that it is required to make such deductions, withholdings and tax
reports. Payments under this Agreement shall be in amounts net of any such
deductions or withholdings. Nothing in this Agreement shall be construed to
require the Company to make any payments to compensate the Executive for any
adverse tax effect associated with any payments or benefits or for any deduction
or withholding from any payment or benefit.
2
<PAGE> 3
(f) Exclusivity of Salary and Benefits. The Executive shall not be
entitled to any payments or benefits other than those provided under this
Agreement. Compliance with the provisions of this Section 4 shall in no way
create or be deemed to create any obligation, express or implied, on the part of
the Company or any of its affiliates with respect to the continuation of any
particular benefit or other plan or arrangement maintained by them or their
subsidiaries as of or prior to the date hereof or the creation and maintenance
of any particular benefit or other plan or arrangement at any time after the
date hereof.
(f) Expenses. The Company shall promptly reimburse the Executive for
all reasonable business expenses incurred by the Executive during the Term in
accordance with the Company 's practices for executive officers of the Company
with a similar level of responsibility, as in effect from time to time.
(g) Vacation. During the Term, the Employee shall receive paid
vacation annually in accordance with the Company 's practices for executive
officers, as in effect from time to time, but in any event not less than four
(4) weeks during each 365 days of the Term.
(h) Auto Allowance. During the Term, the Employee shall receive an
automobile allowance of $600 per month.
(i) Special Bonus. The Executive shall be entitled to receive a
one-time bonus of $100,000 if the Executive is employed by the Company on the
first anniversary of the date of this Agreement.
5. Termination and Termination Benefits. Notwithstanding the
provisions of Section 3, the Executive's employment under this Agreement shall
terminate under the following circumstances set forth in this Section 5.
(a) Termination by the Company for Cause. The Executive's employment
under this Agreement may be terminated for cause without further liability on
the part of the Company effective immediately upon a vote of the Board of
Directors and written notice to the Executive. Only the following shall
constitute "cause" for such termination:
(i) dishonest statements or acts of the Executive with respect
to the Company or any affiliate of the Company or acting in a manner
that discredits or is detrimental to the reputation, character or
standing of the Company or any of its affiliates;
(ii) the commission by or indictment of the Executive for
(A) a felony or (B) any misdemeanor involving moral turpitude, deceit,
dishonesty or fraud, including, without limitation, any form of
harassment ("indictment," for these purposes, means an indictment,
probable cause hearing or any other procedure pursuant to which an
initial determination of probable or reasonable cause with respect to
such offense is made);
3
<PAGE> 4
(iii) the Executive shall commit a breach of any of the
covenants, terms or provisions hereof, which breach has not been
remedied within thirty (30) days after delivery to the Executive by the
Company of written notice of the facts constituting the breach;
(iv) the Executive shall commit a breach of any of the
covenants, terms or provisions of the Non-Competition Agreement, which
breach has not been remedied within thirty (30) days after delivery to
the Executive by the Board of Directors of the Company of written
notice of the facts constituting such breach;
(v) the Executive shall have failed to comply with written
instructions from the Company, which are reasonable and consistent with
Section 2, or shall have substantially failed to perform the
Executive's duties hereunder for a period of thirty (30) days after
written notice from the Company; or
(vi) gross negligence or willful misconduct of the Executive
with respect to the Company or any affiliate of the Company.
Upon termination for cause as provided in this Section 5(a), the
Company shall have any and all rights and remedies under this Agreement and
applicable law in addition to its rights under Section 5(d).
(b) Termination by the Executive. The Executive's employment under
this Agreement may be terminated by the Executive by written notice to the Board
of Directors at least thirty (30) days prior to such termination.
(c) Termination by the Company Without Cause. Subject to the
payment of Termination Benefits pursuant to Section 5(e), the Executive's
employment under this Agreement may be terminated by the Company without cause
upon written notice to the Executive.
(d) Termination by the Executive With Cause. The Executive shall
have the right to terminate his employment hereunder in the event of a material
default by the Company in the performance of its obligations hereunder after the
Executive has given written notice to the Company specifying such default by the
Company and giving the Company a reasonable time, not less than 60 days, to
conform its performance to its obligations hereunder. The parties agree that a
requirement by the Company that the Executive relocate to the Dallas-Ft. Worth,
Texas, area, the location of the Company's principal executive offices, shall
not constitute a material breach by the Company under this Agreement.
(e) Certain Termination Benefits. Unless otherwise specifically
provided in this Agreement or otherwise required by law, all compensation and
benefits payable to the Executive under this Agreement shall terminate on the
date of termination of the Executive's employment under this Agreement.
Notwithstanding the foregoing, in the event of termination
4
<PAGE> 5
of the Executive's employment with the Company pursuant to Section 5(c) or 5(d)
above, the Company shall provide to the Executive the following termination
benefits ("Termination Benefits"):
(i) continuation of the Executive's Salary at the rate then in
effect pursuant to Section 4(a); and
(ii) continuation of group health plan benefits to the extent
authorized by and consistent with 29 U.S.C. Section 1161 et seq.
(commonly known as "COBRA"), with the cost of the regular premium for
such benefits shared in the same relative proportion by the Company
and the Executive as in effect on the date of termination.
The Termination Benefits set forth in (i) and (ii) above shall continue in
effect until the earliest to occur of (i) the last day of the Term; (ii) the
date which is (a) six months after the date of termination if the Executive has
been employed by the Company for less than two years as of the date of
termination (provided, however, that if the Executive has been employed by the
Company for less than one year as of the date of termination, the Company shall
not be required to provide any Termination Benefits to the Executive) or (b)
the first anniversary of the date of termination if the Executive has been
employed by the Company for more than two years as of the date of termination;
and (iii) any breach by the Executive of the Non-Competition Agreement (the
"Termination Benefits Period"). The Company's liability for Salary continuation
pursuant to Section 5(e)(i) shall be reduced by the amount of any severance pay
due or otherwise paid to the Executive pursuant to any (x) severance pay plan
or stay bonus plan of the Company and (y) renumeration due or otherwise paid to
the Executive on account of employment or self-employment for services
performed during the Termination Benefits Period. The Company may, at its
option, elect to pay amounts due under Section 5(e)(i) in a lump-sum.
Notwithstanding the foregoing, nothing in this Section 5(e) shall be construed
to affect the Executive's right to receive COBRA continuation entirely at the
Executive's own cost to the extent that the Executive may continue to be
entitled to COBRA continuation after the Executive's right to cost sharing
under Section 5(e)(ii) ceases. The Executive shall be obligated to give prompt
notice of the date of commencement of any employment or self-employment during
the Termination Benefits Period and shall respond promptly to any reasonable
inquiries concerning any employment or self-employment in which the Executive
engages during the Termination Benefits Period. The parties hereto agree that
the Termination Benefits are to be in full satisfaction, compromise and release
of any claims arising out of any termination of the Employee's employment
pursuant to Section 5(c) or 5(d), and in either case with such amounts to be
contingent upon the Employee's delivery of a general release upon termination
of employment in a form reasonably satisfactory to the Company, it being
understood that no Termination Benefits shall be provided unless and until the
Employee determines to execute and deliver such release.
(f) Death; Disability. Upon the death of the Executive, or upon
the permanent disability (as defined below) of the Executive continuing for a
period in excess of
5
<PAGE> 6
one hundred eighty (180) consecutive days, all obligations of the Company under
this Agreement shall immediately terminate other than any obligation of the
Company with respect to earned but unpaid Salary and benefits contemplated
hereby to the extent accrued or vested through the date of termination. As used
herein, the terms "permanent disability" or "permanently disabled" shall mean
the inability of the Executive, by reason of injury, illness or other similar
cause, to perform a major part of his duties and responsibilities in connection
with the conduct of the business and affairs of the Company, as determined
reasonably and in good faith by the Company. Nothing in this Section 5(f) shall
be construed to waive the Executive's rights, if any, under existing law
including, without limitation, the Family and Medical Leave Act of 1993, 29
U.S.C. Section 2601 et seq. and the Americans with Disabilities Act, 42 U.S.C.
Section 12101 et seq.
(g) Non-Competition Agreement. Notwithstanding termination of
this Agreement as provided in this Section 5 or any other termination of the
Executive's employment with the Company, the Executive's obligations under
Section 6 hereof and in the Executive's Non-Competition Agreement shall survive
any termination of the Executive's employment with the Company at any time and
for any reason as provided therein.
6. Confidential Information and Cooperation.
(a) Confidential Information. As used in this Agreement,
"Confidential Information" means information belonging to the Company which is
of value to the Company in the course of conducting its business and the
disclosure of which could result in a competitive or other disadvantage to the
Company. Confidential Information includes, without limitation, financial
information, reports, and forecasts; inventions, improvements and other
intellectual property; trade secrets; know-how; designs, processes or formulae;
software; market or sales information or plans; customer lists; and business
plans, prospects and opportunities (such as possible acquisitions or
dispositions of businesses or facilities) which have been discussed or
considered by the management of the Company. Confidential Information includes
information developed by the Executive in the course of the Executive's
employment by the Company, as well as other information to which the Executive
may have access in connection with the Executive's employment. Confidential
Information also includes the confidential information of others with which the
Company has a business relationship. Notwithstanding the foregoing, Confidential
Information does not include information in the public domain, unless due to
breach of the Executive's duties under Section 6(b).
(b) Confidentiality. The Executive understands and agrees that the
Executive's employment creates a relationship of confidence and trust between
the Executive and the Company with respect to all Confidential Information. At
all times, both during the Executive's employment with the Company and after his
termination, the Executive will keep in confidence and trust all such
Confidential Information, and will not use or disclose any such Confidential
Information without the written consent of the Company, except as may be
necessary in the ordinary course of performing the Executive's duties to the
Company.
6
<PAGE> 7
(c) Inventions. The Executive recognizes that the Company and its
affiliates possess a proprietary interest in all of the Confidential Information
and have the exclusive right and privilege to use, protect by copyright, patent
or trademark, or otherwise exploit the processes, ideas and concepts described
therein to the exclusion of the Executive, except as otherwise agreed between
the Company and the Executive in writing. The Executive expressly agrees that
any products, inventions, discoveries or improvements made by the Executive or
his agents or affiliates in the course of the Executive's employment, including
any of the foregoing which is based on or arises out of the Confidential
Information, shall be the property of and inure to the exclusive benefit of the
Company. The Executive further agrees that any and all products, inventions,
discoveries or improvements developed by the Executive (whether or not able to
be protected by copyright, patent or trademark) during the course of his
employment, or involving the use of the time, materials or other resources of
the Company or any of its affiliates, shall be promptly disclosed to the Company
and shall become the exclusive property of the Company, and the Executive shall
execute and deliver any and all documents necessary or appropriate to implement
the foregoing.
(d) Business Opportunities. The Executive agrees, while he is
employed by the Company, to offer or otherwise make known or available to it, as
directed by the Board of Directors of the Company and without additional
compensation or consideration, any business prospects, contracts or other
business opportunities that he may discover, find, develop or otherwise have
available to him in any field in which the Company or its affiliates are engaged
or propose to be engaged, and further agrees that any such prospects, contacts
or other business opportunities shall be the property of the Company.
(e) Documents, Records, etc. All documents, records, data,
apparatus, equipment and other physical property, whether or not pertaining to
Confidential Information, which are furnished to the Executive by the Company or
are produced by the Executive in connection with the Executive's employment will
be and remain the sole property of the Company. The Executive will return to the
Company all such materials and property as and when requested by the Company. In
any event, the Executive will return all such materials and property immediately
upon termination of the Executive's employment for any reason. The Executive
will not retain with the Executive any such material or property or any copies
thereof after such termination.
(f) Third-Party Agreements and Rights. The Executive hereby
confirms that the Executive is not bound by the terms of any agreement with any
previous company or other party which restricts in any way the Executive's use
or disclosure of information or the Executive's engagement in any business. The
Executive represents to the Company that the Executive's execution of this
Agreement, the Executive's employment with the Company and the performance of
the Executive's proposed duties for the Company will not violate any obligations
the Executive may have to any such previous company or other party. In the
Executive's work for the Company, the Executive will not disclose or make use of
any information in violation of any agreements with or rights of any such
previous company or
7
<PAGE> 8
other party, and the Executive will not bring to the premises of the Company any
copies or other tangible embodiments of non-public information belonging to or
obtained from any such previous employment or other party.
(g) Litigation and Regulatory Cooperation. During and after the
Executive's employment, the Executive shall cooperate fully with the Company in
the defense or prosecution of any claims or actions now in existence or which
may be brought in the future against or on behalf of the Company which relate to
events or occurrences that transpired while the Executive was employed by the
Company. The Executive's full cooperation in connection with such claims or
actions shall include, but not be limited to, being available to meet with
counsel to prepare for discovery or trial and to act as a witness on behalf of
the Company at mutually convenient times. During and after the Executive's
employment, the Executive also shall cooperate fully with the Company in
connection with any investigation or review of any federal, state or local
regulatory authority as any such investigation or review relates to events or
occurrences that transpired while the Executive was employed by the Company. The
Company shall reimburse the Executive for any reasonable out-of-pocket expenses
incurred in connection with the Executive's performance of obligations pursuant
to this Section 6(g).
(h) Injunction. The Executive agrees that it would be difficult to
measure any damages caused to the Company which might result from any breach by
the Executive of the promises set forth in this Section 6, and that in any event
money damages would be an inadequate remedy for any such breach. Accordingly,
subject to Section 7 of this Agreement, the Executive agrees that if the
Executive breaches, or proposes to breach, any portion of this Agreement, the
Company shall be entitled, in addition to all other remedies that it may have,
to an injunction or other appropriate equitable relief, including, without
limitation, specific performance, to restrain any such breach without posting
bond or showing or proving any actual damage to the Company.
(i) Non-Competition Agreement. The Executive acknowledges that the
Non-Competition Agreement executed and delivered concurrently herewith is an
integral part of his employment arrangements with the Company.
7. Dispute Resolution. Except as provided below, any dispute arising
out of or relating to this Agreement or the breach, termination or validity
hereof shall be finally settled by arbitration conducted expeditiously in
accordance with the Center for Public Resources Rules for Nonadministered
Arbitration of Business Disputes (the "CPR Rules"). The Center for Public
Resources shall appoint a neutral advisor from its National CPR Panel. The
arbitration shall be governed by the United States Arbitration Act, 9 U.S.C.
Sections 1-16, and judgment upon the award rendered by the arbitrators may be
entered by any court having jurisdiction thereof. The place of arbitration shall
be Dallas, Texas.
Such proceedings shall be administered by the neutral advisor in
accordance with the CPR Rules as he/she deems appropriate, however, such
proceedings shall be guided by the following agreed upon procedures:
8
<PAGE> 9
(a) mandatory exchange of all relevant documents, to be
accomplished within forty-five (45) days of the initiation of the procedure;
(b) no other discovery;
(c) hearings before the neutral advisor which shall consist of a
summary presentation by each side of not more than three (3) hours; such
hearings to take place on one or two days at a maximum; and
(d) decision to be rendered not more than ten (10) days following
such hearings.
Notwithstanding anything to the contrary contained herein, the
provisions of this Section 7 shall not apply with regard to any equitable
remedies to which any party may be entitled hereunder.
Each of the parties hereto (a) hereby irrevocably submits to the
jurisdiction of the United States District Court for the Northern District of
Texas for the purpose of enforcing the award or decision in any such
proceeding, (b) hereby waives, and agrees not to assert, by way of motion, as a
defense, or otherwise, in any such suit, action or proceeding, any claim that
it is not subject personally to the jurisdiction of the above-named courts,
that its property is exempt or immune from attachment or execution, that the
suit, action or proceeding is brought in an inconvenient forum, that the venue
of the suit, action or proceeding is improper or that this Agreement or the
subject matter hereof may not be enforced in or by such court, and hereby
waives and agrees not to seek any review by any court of any other jurisdiction
which may be called upon to grant an enforcement of the judgment of any such
court. Each of the parties hereto hereby consents to service of process by
registered mail at the address to which notices are to be given. Each of the
parties hereto agrees that its or his submission to jurisdiction and its or his
consent to service of process by mail is made for the express benefit of the
other parties hereto. Final judgment against any party hereto in any such
action, suit or proceeding may be enforced in other jurisdictions by suit,
action or proceeding on the judgment, or in any other manner provided by or
pursuant to the laws of such other jurisdiction; provided, however, that any
party hereto may at its or his option bring suit, or institute other judicial
proceedings, in any state or federal court of the United States or of any
country or place where the other parties or their assets, may be found.
8. Integration. Except as provided herein, this Agreement constitutes
the entire agreement between the parties with respect to the subject matter
hereof and supersedes all prior agreements between the parties with respect to
any related subject matter, including, without limitation, the employment
agreement between the Executive and Valley Forge dated May 26, 1996, which
agreement is of no further force or effect.
9
<PAGE> 10
9. Assignment; Successors and Assigns, etc. Neither the Company nor
the Executive may make any assignment of this Agreement or any interest herein,
by operation of law or otherwise, without the prior written consent of the
other party; provided that the Company may assign its rights under this
Agreement without the consent of the Executive in the event that the Company
shall effect a reorganization, consolidate with or merge into any other
corporation, partnership, organization or other entity, or transfer all or
substantially all of its properties or assets to any other corporation,
partnership, organization or other entity. This Agreement shall inure to the
benefit of and be binding upon the Company and the Executive, their respective
successors, executors, administrators, heirs and permitted assigns.
10. Enforceability. If any portion or provision of this Agreement
(including, without limitation, any portion or provision of any section of this
Agreement) shall to any extent be declared illegal or unenforceable by a court
of competent jurisdiction, then the remainder of this Agreement, or the
application of such portion or provision in circumstances other than those as
to which it is so declared illegal or unenforceable, shall not be affected
thereby, and each portion and provision of this Agreement shall be valid and
enforceable to the fullest extent permitted by law.
11. Waiver. No waiver of any provision hereof shall be effective
unless made in writing and signed by the waiving party. The failure of any
party to require the performance of any term or obligation of this Agreement,
or the waiver by any party of any breach of this Agreement, shall not prevent
any subsequent enforcement of such term or obligation or be deemed a waiver of
any subsequent breach.
12. Notices. Any notices, requests, demands and other communications
provided for by this Agreement shall be sufficient if in writing and delivered
in person or sent by a nationally recognized overnight courier service or by
registered or certified mail, postage prepaid, return receipt requested, to the
Executive at the last address the Executive has filed in writing with the
Company or, in the case of the Company, at its main offices, attention of the
President and/or Secretary, and shall be effective on the date received.
13. Amendment. This Agreement may be amended or modified only by a
written instrument signed by the Executive and by a duly authorized
representative of the Company.
14. Governing Law. This contract shall be construed under and be
governed in all respects by the laws of the State of Texas, without giving
effect to the conflict of laws principles thereof.
15. Counterparts. This Agreement may be executed in any number of
counterparts, each of which when so executed and delivered shall be taken to be
an original; but such counterparts shall together constitute one and the same
document.
[END OF TEXT]
10
<PAGE> 11
IN WITNESS WHEREOF, this Employment Agreement has been executed as a
sealed instrument by the Company, by its duly authorized officer, and by the
Executive, as of the Effective Date.
COMPANY:
MONARCH DENTAL CORPORATION
By: /s/ Gary W. Cage
-------------------------------
Name: Gary W. Cage
Title: Chief Executive Officer
EXECUTIVE:
/s/ Joseph J. Frank
-----------------------------------
Joseph J. Frank
[EMPLOYMENT AGREEMENT SIGNATURE PAGE]
11
